ヘルペスウイルス感染症

出版社： 臨床医薬研究協会
著者：
発行日： 1996-07-20
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 9784947623188
電子書籍版： 1996-07-20
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,616 円(税込)

購入する

商品紹介

本書「ヘルペスウイルス感染症」は、ヘルペスウイルス感染症に関する知見を一冊にまとめることにより、ヘルペスウイルスの特異性やヘルペスウイルス感染症の診断、治療などにおける課題がより明確になり、今後の進展の一助となることを期待するとともに。実地臨床家の日常診療に益するところが多いものと信じている。ヘルペスウイルス感染症に関する知見を一冊にまとめた。(序文より）

目次

  • 表紙
  • 序文
  • 執筆者一覧
  • もくじ
  • I. ヘルペスウイルスの基礎
  • 1) ヘルペスウイルスの構造と増殖
  • 2) ヘルペスウイルスのDNA
  • 3) ヘルペスウイルスの分子進化的相関
  • 4) ヘルペスウイルスの糖蛋白
  • 5) ヘルペス感染と免疫反応
  • 6) ヘルペスウイルスの血清診断
  • 7) ヘルペスウイルスの遺伝子診断と分子疫学
  • 8) ヘルペスウイルス感染症の病理
  • 9) 抗ヘルペスウイルス薬
  • 10) サイトメガロウイルス
  • 11) EBウィルス
  • 12) ヒトヘルペスウイルス6,7,8の生物学
  • II. 単純ヘルペスの臨床
  • 1) 単純ヘルペスの疫学
  • 2) 単純ヘルペスの伝播と分子疫学
  • 3) 新生児ヘルペス
  • 4) 単純ヘルペス脳炎
  • 5) 皮膚粘膜の単純ヘルペス
  • 6) 男性性器ヘルペス
  • 7) 女性性器ヘルペス
  • 8) ヘルペス性角膜炎
  • 9) 免疫低下と単純ヘルペス
  • III. 水痘・帯状疱疹の臨床
  • 1) 小児の水痘
  • 2) 成人の水痘
  • 3) 帯状疱疹
  • 4) Hunt症候群
  • 5) 眼部帯状疱疹
  • 6) 帯状疱疹後神経痛
  • 7) 水痘ワクチン
  • IV. その他のヘルペスウイルス感染症の臨床
  • 1) 骨髄移植とCMV感染症
  • 2) EBウイルスと伝染性単核症
  • 3) EBウイルスとリンパ腫
  • 4) 慢性活動性EBウイルス感染症
  • 5) HHV-6, HHV-7と突発性発疹
  • 6) AIDSとヘルペス感染症
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. ヘルペスウイルスの基礎

P.14 掲載の参考文献
1) Schrag J.D., Prasad B.V.V., Rixon F.J., Chiu W. : Three-dimentional structure of the HSV-1 nucleocapsid. Cell, 56 : 651-660, 1989.
 
2) Shou Z.H., Prasad B.V.V., Jakana J., Rixon F.J., Chiu W. : Protein subunit structures in the herpes simplex virus A-capsid determined from 400kV spot-scan electron cryomicroscopy. J. Mol. Biol., 242 : 456-469, 1994.
 
3) Haarr L., Skulstad S. : The herpes simplex virus type 1 particle : structure and molecular functions. APMIS, 102 : 321-346, 1994.
PubMed
4) Tatman J.D., Preston V.G., Nicholson P., Elliott R.M., Rixon F.J. : Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses. J. Gen. Virol., 75 : 1101-1113, 1994.
PubMed
5) Newcomb W.W., Trus B.L, Booy F.P., Steven A.C., Wall J.S., Brown J.C. : Structure of the herpes simplex virus capsid. Molecular composition of the pentons and the triplexes. J. Mol. Biol, 232 : 499-511, 1993.
PubMed
6) Cai W., Gu B., Person S. : Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol., 62 : 2596-2604, 1988.
PubMed
7) Ligas M.W., Johnson D.C. : A herpes simplex virus mutant in which glycoprotein D sequences are replaced by β-galactosidase sequences binds to but is unable to penetrate into cells. J.Virol., 62 : 1486-1494, 1988.
 
8) Desai P.J., Schaffer P.A., Minson A.C. : Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1 : evidence that gH is essential for virion infectivity. J. Gen. Virol., 69 : 1147-1156, 1988.
 
9) Stannard LM., Fuller A.O., Spear P.G. : Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope. J. Gen. Virol., 68 : 715-725, 1987.
PubMed
10) Nii S. : Electron microscopic study on the development of herpesviruses. J. Electron Microsc., 41 : 414-423, 1992.
PubMed
11) White D.O., Fenner F.J. : Herpesviridae. In : Medical Virology. Academic Press, San Diego, 1994, pp. 317-347.
 
12) Thomsen D.R, Newcomb W.W., Brown J.C., Homa F.L. : Assembly of the herpes simplex virus capsids : Requirement for the carboxyl-terminal twenty-five amino acids of the proteins encoded by the UL26 and UL26.5 genes. J. Virol., 69 : 3690-3703, 1995.
 
P.26 掲載の参考文献
1) Roizman B., Desrosiers RC., Fleckenstein B., Lopez C., Minson A.C., Studdert M.J. Herpesviridae. In : Virus Taxonomy (ed. by Murphy F.A., et al.) in Archives of Virolgy, suppl.10. Springer-Verlag, Wien, New York, 1995, pp. 114-127.
 
2) Roizman B. : The structure and isomerization of herpes simplex virus genomes. Cell, 16 : 481-494, 1979.
PubMed
3) Wu C.A., Nelson N.J., McGeoch D.J., Challberg M.D. : Identification of herpes simples virus type 1 genes required for origin-dependent DNA synthesis. J. Virol., 62 : 435-443, 1988.
 
4) Sears A.E., Roizman B. : Amplification by host cell factors of a sequence contained within the herpes simplex virus 1 genome. Proc. Natl. Acad. Sci. USA, 87 : 9441-9444, 1990.
PubMed
5) Szostak J.W., Orr-Weaver T.L, Rothstein R.J., Stahl F.W. : The double-strand-break repair model for recombination. Cell, 33 : 25-35, 1983.
PubMed
6) Sakagami K., Tokinaga Y., Yoshikura H., Kobayashi I. : Homology-associated nonhomologous recombination in mammalian gene targeting. Proc. Natl. Acad. Sci. USA, 91 : 8527-8531, 1994.
PubMed
7) Umene K. : Intermolecular recombination of the herpes simplex virus type 1 genome analyses using two strains differing in restriction enzyme cleavage sites. J. Gen. Virol, 66 : 2659-2670, 1985.
 
8) Brown S.M., Subak-Sharpe J.H., Harland J., MacLean A.R. : Analysis of intrastrain recombination in herpes simplex virus type 1 strain 17 and herpes simplex virus type 2 strain HG52 using restriction endonuclease site as unselected markers and temperature-sensitive lesions as selected markers. J. Gen. Virol., 73 : 293-301, 1992.
PubMed
9) Umene K. : Transition from a heterozygous to a homozygous state of a pair of loci in the inverted repeat sequences of the L component of the herpes simplex virus type 1 genome. J. Virol., 61 : 1187-1192, 1987.
 
10) Umene K. : Conversion of a fraction of the unique sequence to part of the inverted repeats in the S component of the herpes simplex virus type 1 genome. J. Gen. Virol., 67 : 1035-1048, 1986.
 
11) Umene K. : Short, duplicated sequence indicative of the recombinogenicity of the junction between a unique and an inverted repeat sequence in the S component of the herpes simplex virus type 1 genome. J. Virol., 63 : 1877-1883, 1989.
 
12) Mocarski E.S., Roizman B. : Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA. Cell, 31 : 89-97, 1982.
PubMed
13) Wohlrab F., Chatterjee S., Wells R.D. : The herpes simplex virus 1 segment inversion site is specifically cleaved by a virus-induced nuclear endonuclease. Proc. Natl. Acad. Sci. USA, 88 : 6432-6436, 1991.
PubMed
14) Nasseri M., Mocarski E.S. : The cleavage recognition signal is contained within sequences surrounding an a-a junction in herpes simplex virus DNA. Virology, 167 : 25-30, 1988.
 
15) Umene K. : Herpes simplex virus type 1 variant a sequence generated by recombination and breakage of the a sequence in defined regions, including the one involved in recombination. J. Virol., 67 : 5685-5691, 1993.
PubMed
16) Umene K. : Excision of DNA fragments corresponding to the unit-length a sequence of herpes simplex virus type 1 and terminus variation predominate on one side of the excised fragment. J. Virol., 68 : 4377-4383, 1994.
 
17) Sarisky RT., Weber P.C. : Requirement for double-strand breaks but not for specific DNA sequences in herpes simplex virus type 1 genome isomerization events. J. Virol., 68 : 34-47, 1994.
 
18) Umene K. : Recombination of the internal direct repeat element DR2 responsible for the fluidity of the a sequence of herpes simplex virus type 1. J. Virol., 65 : 5410-5416, 1991.
PubMed
19) Cunningham C., Davison A. J. : A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology, 197 : 116-124, 1993.
PubMed
20) McGeoch DJ., Dalrymple M.A., Davison A.J., Dolan A., Frame M.C., McNab D., Perry LJ., Scott J.E., Taylor P. : The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol, 69 : 1531-1574, 1988.
 
21) Honess R.W. : Herpes simplex and "the herpes complex" : diverse observations and a unifying hypothesis. J. Gen. Virol., 65 : 2077-2107, 1984.
 
22) McGeoch DJ., Cook S., Dolan A., Jamieson F.E., Telford E.A.R. : Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol., 247 : 443-458, 1995.
 
23) Whitton J. L, Clements J. B. : The junctions between the repetitive and the short unique sequences of the herpes simplex virus genome are determined by the polypeptide-coding regions of two spliced immediate-early mRNAs. J. Gen. Virol, 65 : 451-466, 1984.
PubMed
24) Sakaoka H., Kurita K., Iida Y., Takada S., Umene K., Kim Y.T., Ren C.S., Nahmias AJ. : Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries : studies of molecular evolution and molecular epidemiology of the virus. J. Gen. Virol., 75 : 513-527, 1994.
PubMed
25) Umene K., Yoshida M. : Genomic characterization of two predominant genotypes of herpes simplex virus type 1. Arch. Virol., 131 : 29-46, 1993.
PubMed
26) Sakaoka H., Saito H., Sekine K., Aomori T., Grillner L., Wadell G., Fujinaga K. : Genomic comparison of herpes simplex virus type 1 isolates from Japan, Sweden and Kenya. J. Gen. Virol., 68 : 749-764, 1987.
 
27) Umene K., Yoshida M. : Preparation of herpes simplex virus type 1 genomic markers to differentiate strains of predominant genotypes. Arch. Virol., 138 : 55-69, 1994.
PubMed
28) Umene K., Sakaoka H. : Homogeneity and diversity of genome polymorphism in a set of herpes simplex virus type 1 strains classified as the same genotypic group. Arch. Virol., 119 : 53-65, 1991.
 
29) Umene K., Yoshida M. : Reiterated sequences of herpes simplex virus type 1 (HSV-1) genome can serve as physical markers for the differentiation of HSV-1 strains. Arch. Virol., 106 : 281-299, 1989.
PubMed
30) Weir J.P., Elkins K.L. : Replication-incompetent herpesvirus vector delivery of an interferon α gene inhibits human immunodeficiency virus replication in human monocytes. Proc. Natl. Acad. Sci. USA, 90 : 9140-9144, 1993.
 
P.36 掲載の参考文献
1) 森良一(監修) : ヘルペスウイルス (One point illustrated key words), メディカルレビュー社, 1995.
 
2) 坂岡博, 栗田啓子, 出村守 : 単純ヘルペスウイルスのDNA診断法とその分子疫学・分子進化学への応用. 臨床とウイルス, 増刊号 (ウイルス検査法), 23 : 120-126, 1995.
 
3) Chang Y., Cesarman E., Pessin M.S., et al. : Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266 : 1865-1869, 1994.
PubMed
4) Gompels U.A., Nicholas J., Lawrence G., et al. : The DNA sequence of human herpes-6 : Structure, coding content, and genome evolution. Virology, 209 : 29-51, 1995.
 
5) McGeoch D.J. : The genomes of the human herpesviruses : contents, relationships, and evolution. Ann. Rev. Microbiol., 43 : 235-265, 1989.
 
6) McGeoch D.J., Cook S. : Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale. J. Mol. Biol., 238 : 9-22, 1994.
 
7) McGeoch D.J., Cook S., Dolan A., et al. : Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol.Biol, 247 : 443-458, 1995.
PubMed
8) Roizman B., Carmichael L.E, Deinhardt F., et al. : Herpesviridae. Definition, provisional nomenclature and taxonomy. Intervirology, 16 : 201-217, 1981.
PubMed
9) Roizman B., Desrosiers R.C., Fleckenstein B., et al. : The family Herpesviridae : an update. Arch. Virol., 123 : 425-449, 1992.
 
10) Sakaoka H., Kurita K., Iida Y., et al. : Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries : Studies of molecular evolution and molecular epidemiology of the virus. J. Gen. Virol., 75 : 513-527, 1994.
PubMed
11) Nei M. : Molecular evolutionary genetics. Columbia University Press, 1987.
 
P.43 掲載の参考文献
1) 森良一, 川名尚(編) : ヘルペスウイルス感染症. メディカルトリビューン, 1986.
 
2) 高橋理明, 新村眞人 : 水痘・帯状疱疹. メディカルトリビューン, 1987.
 
3) Fields B.N., Knipe D.M. : Fields Virology. Reven Press, 1990.
 
4) Campadelli-Fiume G. : Virus glycoproteins. In : Encyclopedia of Virology (ed. by Webster R.G., Granoff A.) Academic Press, London, 1994, pp. 603-608.
 
5) Straus S.E., Corey L, Burke R.L, Savarese B., Barnum G., Krause PR, Kost R.G., Meier J. L, Sekulovich R., Adair S. F., Dekker C. L. : Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet, 343 : 1460-1463, 1994.
 
6) Shiraki K., Takahashi M. : Virus particles and glycoproteins excreted from cultured cells infected with varicella-zoster virus (VZV). J. Gen. Virol., 61 : 271-275, 1982.
PubMed
7) Shiraki K., Okuno T., Yamanishi K., Takahashi M. : Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). J. Gen. Virol., 61 : 255-269, 1982.
PubMed
8) Okuno T., Yamanishi K., Shiraki K., Takahashi M. : Synthesis and processing of glycoproteins of varicella-zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. Virology, 129 : 357-368, 1982.
PubMed
9) Namazue J., Kato T., Okuno T., Shiraki K., Yamanishi K. : Evidence for attachment of fatty acid to varicella-zoster virus glycoproteins and effect of cerulenin on the maturation of varicella-zoster virus glycoproteins. Intervirology, 30 : 268-277.
PubMed
10) Matsui S., Okuno T., Shiraki K. : Functional roles of terminal glycomoieties in varicella-zoster virus infection. Virology, 198 : 50-58, 1994.
PubMed
11) Herold B.C., Wudun D., Soltys N., Spear P.G. : Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol., 65 : 1090-1098, 1991.
 
12) Shieh M.-T., WuDunn D., Montgomery R.I., Esko J.D., Spear P.G. : Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol., 116 : 1273-1281, 1992.
PubMed
13) Fuller A.O., Spear P.G. : Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proc. Natl. Acad. Sci. USA, 84 : 5454-5458, 1987.
PubMed
14) Highlander S. L., Cai W. H., Person S., Levine M., Glorioso J. C. : Monoclonal antibodies difine a domain on herpes simplex virus glycoprotein B involved in virus penetration. J. Virol., 61 : 3356-3364, 1988.
 
15) Desai P.J., Schaffer P.A., Minson A.C. : Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1 : evidence that gH is essential for virion infectivity. J. Gen. Virol., 69 : 1147-1156, 1988.
 
16) Campadelli-Fiume G., Arsenakis F., Farabegoli F., Roizman B. : Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus. J. Virol, 64 : 6070-6079, 1988.
 
17) Dean H. K., Warner M. S., Terhune S. S., Johnson R. M., Spear P. G. : Viral determinants of the variable sensitivity of herpes simplex virus strains to gD-mediated interference. J. Virol., 69 : 5171-5176, 1995.
 
18) Koszinowski U.H., Jonjic S., Lucin P. : Cytomegalovirus persistance by evasion from immune control. Seminars in Virology, 5 : 297-305, 1994.
 
19) Yamashita Y., Shimokata K., Mizuno S., Yamaguchi H., Nishiyama Y. : Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus. Virology, 193 : 727-736, 1993.
PubMed
20) Yamashita Y., Shimokata K., Saga S., Mizuno S., Tsurumi T., Nishiyama Y. : Rapid degradation of the heavy chain of class I MHC histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells. J. Virol., 68 : 7933-7943, 1994.
 
21) Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. : Herpes simplex virus turns off the TAP to evade host immunity. Nature, 375 : 411-415, 1995.
PubMed
22) Baba K., Shiraki K., Kanesaki T., Yamanishi K., Ogra P.L., Yabuuchi H., Takahashi M. : Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections. J. Clin. Microbiol., 25 : 2193-2196, 1987.
PubMed
23) Takahashi M., Iketani T., Sasada K., Hara J., Kamiya H., Asano Y., Baba K., Shiraki K. : Immunization of elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen. J. Infect. Dis., 166(Suppl.1) : 58-62.
 
24) Shiraki K., Yamanishi K., Takahashi M. : Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus. J. Infect. Dis., 149 : 501-504, 1984.
PubMed
25) Burke R. L, Goldbeck C., Ng P., Stanberry L., Ott G., Van Nest G. : The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine. J. Infect. Dis., 170 : 1110-1119, 1994.
PubMed
26) Ghiasi H., Bahri S., Nesburn A. B., Wechsler S. L. : Protection against herpes simplex virus-inducedeye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Investigative Ophthalmology & Visual Science, 36 : 1352-1360, 1995.
 
27) Masuho Y., Matsumoto Y., Sugano T., Fujinaga S., Minamishima Y. : Human monoclonal antibodies neutralizing human cytomegalovirus. J. Gen. Virol., 68 : 1457-1461, 1987.
PubMed
28) 臼井正彦, 島田馨, 望月學, 佐々木一之, 山村敏明, 田中稔, 坂井潤一, TI-23CMV網膜炎研究会 : 抗サイトメガロウイルス(CMV)ヒトモノクローナル抗体のCMV網膜炎に対する臨床試験成績. 薬理と治療, 22 : 4159-4177, 1994.
Medical*Online
P.54 掲載の参考文献
1) Cook M.L., Stevens J.G. : Pathogenesis of herpetic neuritis and ganglionitis in mice : evidence of intra-axonal transport of infection. Infect. Immun., 7 : 272-289, 1973.
PubMed
2) Roizman B., Sears A. : An inquiring into mechanisms of herpes simplex virus latency. Ann. Rev. Microbiol., 41 : 543-571, 1987.
 
3) Roizman B. : An inquiry into the mechanisms of recurrent herpes infections in men. In : Perspectives in Virology IV (ed. by Pollard M.), Harper & Row, N.Y., 283, 1968.
 
4) Whitley R.J., Corey L., Arvin A. : Changing presentation of neonatal herpes simplex virus infection. J.Infect. Dis., 158 : 109-116, 1988.
 
5) Sullivan-Bolyai J., Hull H.F., Wilson C., Corey L. : Neonatal herpes simplex virus infection in King County, Washington : increasing incidence and epidemiologic correlates. JAMA, 250 : 3059-3062, 1983.
PubMed
6) Nahmias A.J., Keyserling H.L., Kerrick G.M. : Herpes simplex. In : Infectious diseases of fetus and newborn infant (ed. by Ramington J.S., Klein J.O.), W.B. Sanders, Philadelphia, 1983, pp. 636-678.
 
7) Nahmias A.J., Josey W.E., Naib Z.M., Luce C., Duffey C. : Antibodies to herpesvirus hominis type 1 and 2 in humans. I. Patients with genital herpetic infections. Am. J. Epidemiol., 91 : 539-546, 1970.
 
8) Whitley R.J., Spruance S., Hayden F.G., Overall J., Alford C.A. Jr., Gwaltney J.M. Jr., Soong S.J., NIAID Collaborative Antiviral Study Group : Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J. Infect. Dis., 149 : 1-8, 1984.
 
9) Rand K.H., Rasmussen L.E., Pollard RB., Arvin A.M., Merigan T.C. : Cellular immunity and herpes virus infections in cardiac transplant patients. N. Engl. J. Med., 75 : 1372-1377, 1977.
 
10) Mann S.L, Meyers J.D., Holmes K.L, Corey L. : Prevalence and incidence of herpesvirus infections among homosexually active men. J. Infect. Dis., 149 : 1026, 1984.
 
11) Whitley R.J., Soong S.J., Hirsch M.S., Karchmer A.W., Dolin R., Galasso G., Dunnick J.K., Alford C.A., NIAID Collaborative Antiviral Study Group : Herpes simplex encephalitis : vidarabine therapy and diagnastic problems. N. Engl. J. Med., 304 : 313-318, 1981.
 
12) Schlitt M., LaKeman A.D., Wilson E.R., To A., Acoff R.W., Harsh G.R.III, Whitley R.J. : A rabbit model of focal herpes simplex encephalitis. J. Infect. Dis., 153 : 732-735, 1986.
 
13) Whitley R.J., Kern E., Chattopadhay S., Chou J., Roizman B. : Replication, establishment of latency and induced reactivation of herpes simplex virus γ1 34.5 deletion mutants in rodent models. J. Clin. Invest., 91 : 2837-2843, 1993.
 
14) Perng G.C., Thompson R.L., Sawtell N.M., Taylor W.E., Slanina S.M., Kaiwar R, Nesburn A.B., Wechsler S.L. : An avirulent ICP 34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spunaneous reactivation. J. Virol., 69 : 3033-3041, 1995.
 
15) Chou J., Kern E.R., Whitley R.J., Roizman B. : Mapping of herpes simplex virus-1 neurovirulence to γ1 34.5 ; a gene non essential for growth in culture. Science, 250 : 1262-1266, 1990.
 
16) McKie E.A., Hope R.G., Brown S.M., MacLean A.R. : Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system. J. Gen. Virol., 75 : 733-741, 1994.
 
17) Shieh M.T., WuDunn D., Montogomery R.I., Esko J.D., Spear P.G. : Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol., 116 : 1273-1281, 1992.
 
18) Wudunn D., Spear P.G. : Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol, 63 : 52-58, 1989.
PubMed
19) Campadelli-Fume G., Strpe D., Boscaro A., Avitabile E, Fou-Tomasi L., Baker D., Rolzman B. : Glycoprotein C-dependent attachment of herpes simplex virus to susceptible cells leading to productive infection. Virology, 178 : 213-222, 1990.
 
20) Fujihara T., Hayashi K. : Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch. Virol., 140 : 1469-1472, 1995.
PubMed
21) Mogensen S.C. : Role of macrophages in natural resistance to virus infections. Microbiol. Rev., 43 : 1-26, 1979.
PubMed
22) Morahan P.S., Connor J.R., Leary K.R. : Viruses and the versatile macrophage. Br. Med. Bull, 41 : 15-21, 1985.
PubMed
23) Wu L., Morahan P.S. : In : Herpes simplexvirus (ed. by Rouse B.T.), Springer-Verlag. Berlin, 1992, pp. 89-110.
 
24) Hayashi, K., Kurata T., Morishima T., Nassery T. : Analysis of the inhibitory effect of peritoneal macrophages on the spread of herpes simplex virus. Inf. Immun., 28 : 350-358, 1980.
 
25) Morse S.S., Morahan P.S. : Activated macrophages mediate interferon-independent inhibition of herpes simplex virus. Cell Immunol, 58 : 72-84, 1981.
PubMed
26) Koff W.C., Showalter S.D., Seniff D.A., Hamper B. : Lysis of herpesvirus-induced cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma. Inf. Immun., 42 : 1067-1072, 1983.
 
27) Morgensen S.C., Ellermann-Eriksen S., Sommerlund M. : Herpes simplex virus type 2 primes mouse macrophages for an early and genetically determined respiratory burst mediated by interferon α/β. J. Gen. Virol., 70 : 1371-1379, 1989.
 
28) Ellermann-Eriksen S. : Autocrine secretion of interferon α/β and tumour necrosis factor-α synergistically activates mouse macropheges after in fection with herpes simplex virus type 2. J. Gen. Virol., 74 : 2191-2199, 1993.
 
29) Ellermann-Erikson S., Liberto M.C., Iannello D., Morgensen S.C. : X-linkage of the early in vitro α/β interferon response of mouse peritoneal marcrophages to herpes simplex virus type 2. J. Gen. Virol., 67 : 1025-1033, 1986.
 
30) Kirchner H., Engler H., Schroder C.H., Zawatzky R., Storch E. : Herpes simplex virus type 1-induced interferon production and activation of natural killer cells in mice. J. Gen. Virol., 64 : 437-441, 1983.
PubMed
31) Johnson R.T. : The pathogenesis of herpes virus encephalitis. II. A cellular basis for the development of resistance with age. J. Exp. Med., 120 : 359-374, 1964.
 
32) Trincheiri G., Perussia, B. : Human natural killer cells : biologic and pathologic aspects. Lab. Invest., 50 : 489-513, 1984.
 
33) Diamond R.D., Keller R., Leo G., Finkel D. : Lysis of cytomegalovirus-infected human fibroblasts and transformed human cells by peripheral blood lymphoid cells from normal human donors. Pro. Soc. Exp. Biol. Med., 154 : 259-263, 1977.
 
34) Welsh R.M., Zinkernagel R.M. : Heterospecific cytotoxic cellactivity induced during the first three days of a cute lymphocytic choriomeningitis virus infection in mice. Nature, London, 268 : 646-648, 1977.
 
35) Herberman R.B., Nunn M.E., Holden H.T., Steal S., Djeu J.Y. : Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int. J. Cancer, 19 : 555-564, 1977.
 
36) Santoli D., Trincheri G., Lief, F.S., : Cell-mediated cytotoxicity against virus-infected target cells in humans : 1. Characterization of the effector lymphocyte. J. Immunol., 121 : 526-531, 1978.
 
37) Welsh R.M. : Mouse natural killer cells : induction specificity and function. J. Immunol., 121 : 1631-1635, 1978.
PubMed
38) Lanier L.L, Phillips J.H., Hackett J., Tutt M., Kumar V. : Natural killer cells : Definition of a cell type rather than a function. J. Immunol., 137 : 2735-2739, 1986.
PubMed
39) Bishop G.A., Glorioso J.C., Schwartz S.A. : Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J. Exp. Med., 157 : 1544-1553, 1983.
PubMed
40) Rager-Zisman B., Quan P.C., Rosner M., Moller J.R., Bloom B.R. : Role of NK cells in protection of mice against herpes simplex virus-1 infection. J. Immunol., 138 : 884-888, 1987.
PubMed
41) Biron C.A., Byron K.S., Sullivan J.L. : Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med., 320 : 1731-1735, 1989.
 
42) Miyazaki D., Araki-Sasaki K., Inoue Y., Shimomura Y., Hayashi K. : Neutrophil chemotaxis induced by corneal epithelial cells after herpes simplex type 1 infection. Invest. Ophthal. Vis. Sci., 37 : S46, 1996.
 
43) Rouse B.T., Babiuk L.A., Aenson P.M. : Neutrophils in antiviral immunity : inhibition of virus replication by a mediator produced by bovine neutrophils. J. Infect. Dis., 141 : 223-232, 1980.
 
44) Ashkenzai M., Kohl S. : Reduced antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells of salivary polymorphonuclear leukocytes and inhibition of periphreral blood polymorphonuclear leukocyte cytotoxicity by saliva. J. Immunol., 144 : 478-4787, 1990.
 
45) Van Strijp J.A.G., Van Kessel K.P.M., Van Der Tol M.E., Verhoef J. : Phagocytosis of herpes simplex virus by human granulocytes and monocytes. Arch. Virol., 104 : 287-298, 1989.
 
46) Van Strijp J.A.G., Van Kessel K.P.M., Van Del Tol M.E, Verhoef J. : Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion. J. Clin. Invest., 84 : 107-112, 1989.
PubMed
47) Sprecher E., Becker Y. : Skin Langerhans cells play an essential role in the difense against HSV-1 infection. Arch. Virol., 91 : 341-349, 1986.
PubMed
48) Otani T., Mori R. : The effect of ultraviolet irradiation of the skin on herpes simplex virus infection : alteration in immune function mediated by epidermal cells and in the course of infection. Arch. Virol., 96 : 1-15, 1987.
PubMed
49) Thomas E.E., Lau A.S., Kim S.U, Osborne D., Kastrukoff L.E. : Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice. J. Gen. Virol., 72 : 2051-2057, 1991.
 
50) Milligan G.N., Bernstein D.I. : Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex type 2. Virology, 212 : 481-489, 1995.
PubMed
51) Smith P.M., Wolcott R.M., Chervenak R., Jenning S.R. : Control of acute cutaneous herpes simplex virus infection : T cell mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology, 202 : 76-88, 1994.
 
52) Manickan E, Rouse R.J.D., Yu Z., Wire W.S., Rouse B.T. : Genetic immunization against herpes simplex virus : Protection is mediated by CD4+ T lymphocytes. J. Immunol., 155 : 259-265, 1995.
 
53) Rossol-Voth R, Rossol S., Schutt K.H., Cornidori S., De Cian W., Falke D., : In vivo protective effect of tumour necrosis factor α against experimental infection with herpes simplex virus type 1. J. Gen. Virol., 72 : 143-147, 1991.
 
54) Feduchi E., Carrasco L. : Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon gamma. Virology, 180 : 822-825, 1991.
PubMed
55) Ellermann-Eriksen S. : Autocrine secretion of interferon-α/β and tumour necrosis factor-α synergistically activates mouse macrophages after infection with herpes simplex virus type 2. J.Gen. Virol., 74 : 2191-2199, 1993.
 
56) Burns, W.H., Billups L.C., Notkins A.L. : Thymus dependence of viral antigens. Nature, 256 : 654-656, 1975.
 
57) Eis-Hubinger A.M., Schmidt, D.S., Schneweis K.E. : Antiglycoprotein B monoclonal antibody protects mice against genital herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol., 74 : 379-385, 1993.
PubMed
58) Gallichan, W.S., Johnson D.C., Graham F.L., Rosenthal K.L. : Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex glycoprotein B. J. Infect. Dis., 168 : 622-629, 1993.
 
59) Sanchez-Pescador L., Pereird L, Charlebois E.D., Kohl S. : Antibodies to epitopes of herpes simplex type 1 glycoprotein B (gB)in human sera : Analysis of functional gB epitopes definod by inhibition of murine monoclonal antibodies. J. Infect. Dis., 168 : 844-853, 1993.
 
60) Cantin E.M., Ebele R., Baldick J.L, Moss B., Willey E.D., Notkins A.L., Openshaw H. : Expession of herpes simplex virus 1 glycoprotein B by a recombinant vacciniavirus and profection of mice against lethal herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. USA, 84 : 5908-5912, 1987.
 
61) Ross C., Glorioso J., Sacks S., Lavery C., Rawls W.E. : Competitive inhibition by human sera of mouse monoclonal antibody binding to glycoprotein C and D of herpes simplex virus types 1 and 2. J. Virol., 54 : 851-855, 1985.
 
62) Weir J.P., Bennett M., Aller E.M., Elkins K.L., Martin S., Rouse B.T. : Recombinant vacciniavirus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. J. Gen. Virol., 70 : 2587-2594, 1989.
 
63) Rooney J.F., Wohlenberg C., Cremer K.J., Notkins A.L. : Immunized mice challanged with herpes simplex virus by the intranasal route show protection against latent infection. J. Infect. Dis., 159 : 974-976, 1989.
 
64) Lasky L.A., Dowbenko D., Simonsen C.C., Berman. P.W. : Protection of mice from lethal herpes simplex virus infection by vaccination with a secreted form of cloned glycoprotein D. Biotechnology, 2 : 527-532, 1984.
 
65) Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. : Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challange. Virology, 188 : 469-476, 1992.
 
66) Forrester A.J., Sulliran V., Simmons A., Blacklaws B.A., Smith G.-L., Nash A.A., Minson A.C. : Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vuccinia virus. J. Gen. Virol., 72 : 369-375, 1991.
 
67) Ghiasi H., Kaiwar R, Nasburn A.B., Wechsler S.L. : Baculovirus-expressed glycoprotein H of herpes simplex type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge. J. Gen. Virol., 73 : 719-722, 1992.
 
68) Browne H., Baxter V., Minson T. : Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1. J. Gen. Virol., 74 : 2813-2817, 1993.
 
69) Ishizaka S.T., Piaconte P., Silva J., Mishkin EM. : IgG subtype is correlated with efficacy of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies. J. Infect. Dis., 172 : 1108-1111, 1995.
 
70) Manickan E, Rouse R.J.D., Yu Z., Wire W.S., Rouse B.T. : Genetic immunization against herpes simplex virus protection is mediated by CD4+ T lymphocytes. J. Immunol., 155 : 259-265, 1995.
 
71) Bowen J.C., Alpar H.O., Phillpots R., Brown M.R.W. : Mucosal delivery of herpes simplex virus vaccine. Research in Virology, 143 : 269-278, 1992.
 
72) Milligan G.N., Bernstein D.I. : Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology, 206 : 234-241, 1995.
PubMed
73) Irie H., Harada Y., Kataoka M., Nagamuta M., Moriya Y., Handa M., Saito M., Matsubara S., Kojima K., Sugawara Y. : Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine. J. Virol., 66 : 2428-2434, 1992.
PubMed
74) Irie H., Shimeld C., Williams N., Hill T. : Protection against ocular and cutaneous infection with herpes simplex virus type 1 by gastric immunization with live virus. J. Gen. Virol., 74 : 1357-1362, 1993.
PubMed
75) Lodmell D.-L., Niwa A., Hayashi K., Notkins A.L. : Prevention of cell to cell spread of herpes simplex virus by leukocytes. J. Exp. Med., 137 : 706-720, 1973.
PubMed
76) Simmons A., Nash A.A. : Role of antibody in primary and recurrent herpes simplex virus infection. J. Virol., 53 : 944-948, 1985.
PubMed
77) Balachandran N., Bacchetti S., Rawls W.E. : Protection against lethal challenge of Balb/c mice by passive transfer to monoclonal antibodies to five glycoprotoins of herpes simplex virus type 2. Infect. Immun., 37 : 1132-1337, 1982.
PubMed
78) Mester J.C., Glorioso J.C., Rouse B.T. : Protection against zosteriform spread of herpes simplex virus by monoclonal antiobodies. J. Infect. Dis., 163 : 263-269, 1991.
 
79) Frank I., Friedman H.M. : A novel function of the herpes simplex virus type 1 Fc receptor : participation in bipolar bridging of antiviral immunoglobulin G. J. Virol., 63 : 4479-4488, 1989.
PubMed
80) Bell S., Cranqe M., Borysiewicz L., Minson T. : Induction of immunoglobulin G Fc receptors byrecombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1. J. Virol., 64 : 2181-2186, 1990.
PubMed
81) Nahmias A.J., Josey W.E., Naib Z.M., Freeman M.G., Fernandez RJ., Wheeler J.H. : Perinatalrisk associated with maternal genital herpes simplex virus infection. Am. J. Obstet. Gynecol., 110 : 825-836, 1971.
 
82) Prober C.G., Sullender W.M., Yasukawa L.L., Au D.S., Yeager A.S., Arvin A.M. : Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N. Engl. J. Med., 316 : 240-244, 1987.
 
83) Brown Z.A., Benedetti J., Ashley R., Burchett S., Selke S., Berry S., Vontver L.A., Corey L. : Neonatal herpes simplex virus infection in relation to a symptomatic maternal infection at the time of labor. N. Engl. J. Med., 324 : 1247-1252, 1991.
 
84) Linnenman C.C. Jr., May D.B., Schubert W.K., Caraway C.T., Schiff G.M. : Fatal viral encephalitisin children with X-linked hypogammaglobulinemia. Am. J. Dis. Child., 126 : 100-103, 1973.
 
85) Olson N.Y., Hall J.C. : Chronic cutaneous herpes simplex and X-linked hypogammaglobulinemia. Pediatr. Dermatol., 4 : 225-228, 1987.
 
86) Kohl S., Foigin R.D., Cherry J.D., ed. : Textbook of pediatric infections diseases. 2nd ed., Saunders, Philadelphia, 1987. pp. 1577-1601.
 
87) Townsend A.R., Rothbard J., Gotch F.M., Bahadur G., Wraith D., McMichael A.J. : The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with shortsynthetic peptides. Cell, 44 : 959-968, 1986.
 
88) Bjokman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L, Wiley D.C. : The foreignantigen binding site and T cell recognition regions of class I histocompatibility antigen. Nature, 329 : 512-518, 1987.
 
89) Rudensky A.Y., Preston-Hurlburt P., Hong S.C., Barlow A., Jareway Jr. C.A. : Sequence analysis of peptides bound to MHC class II molecules. Nature, 353 : 622-627, 1991.
 
90) Berzofsky J.A., Brett S.J., Streicher H.Z., Takahashi H. : Antigen processing for presentation to T lymphocytes : function, mechanisms, and implications for the T-cell repertoire. Immunol. Rev., 106 : 5-31, 1988.
 
91) Braciale J.J., Braciale V.L. : Antigan presentation : structural themes and fuctional variations. Immunology Today, 12 : 124-129, 1991.
 
92) Vasilakos J.P., Michael J.G. : Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells. J. Immunol., 150 : 2346-2355, 1953.
 
93) Bonneau R.H., Salvucci L.A., Johnson D.C., Tevethia S.S. : Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocytes clones. Virology, 195 : 62-70, 1993.
PubMed
94) Johnson R.M., Lancki D.W., Fitch F.W., Spear P. : Herpes simplex virus glycoprotein D is recongnized as antigen by CD4+ and CD8+ T lymphocytes from infected mice : characterization of T cell clones. J. Immunol., 145 : 702-710, 1990.
 
95) Martin S., Moss B., Barman P.W., Laskey L.A., Rouse B.T. : Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D : Cytotoxic T cells. J. Virol., 61 : 726-734, 1987.
 
96) Glorioso J., Kees U., Kumel G., Kirchner H., Krammer P.H. : Identification of herpes simplex virus type 1 (HSV-1) glycoprotein C as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. J. Immunol., 135 : 575-582, 1965.
 
97) Tigges M.A., Koelle D., Hartog K., Sakulovich R.E, Corey L., Burke R.L., : Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognized diverse virion protein antigens. J.Virol., 66 : 1622-1634, 1992.
 
98) Martin S., Zhu X., Silverstein SJ., Courtney R., Yao F., Jenkins FJ., Rouse B.T. : Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICPO. J. Gen. Virol., 71 : 2391-2399, 1990.
PubMed
99) Banks T.A., Allen EM., Dasgupta S., Sandri-Goldin R., Rouse B.T. : Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27. J. Virol., 65 : 3185-3191, 1991.
PubMed
100) Banks T.A., Nair S., Rouse B.T. : Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus. J. Virol., 67 : 613-616, 1993.
PubMed
101) Falk K., Rotzsohke O., Deres K., Metzger J., Tung G., Rammeusee H.G. : Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med., 174 : 425-434, 1991.
 
102) Yewdell J.W., Eisenlohr L., Cox J.H., Esquivel F., Anderson R.W., Lapham C.K., French R., Bennink J.R. : Viruses and the cellular immune response (ed. by Thomas D.B.), Marcel Dekkar Inc., N.Y., 1993. pp. 31-48.
 
103) Jones P.P., Murphy D.B., Hewgill D., McDevitt H.O. : Detection of a common polypeptide chain in I-A and I-E sub-region immunoprecipitates. Immunochemistry, 16 : 51-60, 1979.
 
104) Nuchtern J.G., Biddison W.E., Klausner R.D. : Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature, 343 : 74-76, 1990.
PubMed
105) Mosmann TR., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. : Two types of murine helper T cell clone 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136 : 2348-2352, 1986.
PubMed
106) O'Garra A. : Viruses and the cellular immune response (ed. by Thomas D.B.), Marcel Dekker Inc., N.Y., 1993. pp. 75-99.
 
107) Moldwin R.L., Lancki D.W., Herold K.C., Fitch F.W. : An antigen receptor-driven, interleukin 2-independent pathway for proliferation of murine cytotoxic T lymphocyte clones. J. Exp. Med., 163 : 1566-1582, 1986.
PubMed
108) Nash A.A., Jayasuriya A., Phelan J., Cobbold S.P., Waldmann H., Prospero T. : Different relesfor L3T4+ and Lyt2+ T-cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol., 68 : 825-833, 1987.
 
109) Larsen H.S, Feng M.F., Horohov D.W., Moore R.N., Rouse B.T. : Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J. Virol., 50 : 56-59, 1984.
PubMed
110) Howes E.L., Taylor W., Mitchinson N.A., Simpson E. : MHC matching shows that at least two T-cell subsets determine resistance to HSV. Nature, 277 : 67-68, 1979.
 
111) Yasukawa M., Inatsuki A., Kobayashi Y. : Differential in vitro activation of CD4+ CD8-and CD8+ CD4-herpes simplex virus specific cytotoxic T cells. J. Immunol., 143 : 2051-2057, 1989.
PubMed
112) Schmid D.S. : The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+ CD8-T cells and is restricted to the DR region of MHC complex. J. Immunol., 140 : 3610-3616, 1988.
 
113) Torpey DJ. III, Lindsley M.D., Rinaldo C.R. Jr. : HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes. J. Immunol., 142 : 1325-1332, 1989.
 
114) Maccario R, Revello M.G., Comoli P., Gerna G. : Herpes simplex virus-specific human cytotoxic T lymphocytes are induced in vitro by autologous virus-infected mononucldear cells. Vir. Immunol., 5 : 93-103, 1992.
 
115) Maccario R., Revello M.G., Comoli P., Montagna D., Localelli F., Gerna G. : HLA-unrestricted killing of HSV-1-infected mononuclear cells : Involvement of either γ/δ+ or α/β+ human cytotoxic T lymphocytes. J. Immunol., 150 : 1437-1446, 1993.
 
116) Maccario R., Comoli P., Percivalle E., Mantagna D., Locatelli F., Gerna G. : Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either γδ or αβ T-cell receptor : role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Immunology, 85 : 49-56, 1995.
 
117) Williams N.A., Hill J., Hooper D.C. : Murine epidermal antigen-presenting cells in primary andsecondary T-cell proliferative responses to herpes simplex virus in vitro. Immunology, 72 : 34-39, 1991.
 
118) Raulet D.H. : The stracture, function and molecular genetics of the γδ T cell receptor. Ann. Rev. Immunol., 7 : 175-207, 1989.
 
119) Johnson R.M., Lancki D.W., Sperling A.I., Dick R.F., Spear P.G., Fitch F.W., Bluestone J.A. : Amurine CD4-, CD8- T cell receptor-γδ T lymphocyte clone specific for herpes simplex virus glycoprotein I. J. Immunol., 148 : 983-988, 1992.
 
120) Griffin J.D., Hercend T., Beveridge R., Scholssman S.F. : Characterization of an antigen expressed by human natural killer cells. J. Immunol., 130 : 2947-2951, 1983.
 
121) Lanier L.L., Le A.M., Civin C.I., Loken, M.R., Phillips J.H. : The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol., 136 : 4480-4486, 1986.
 
122) Tal-Singer R., Seidel-Dugan C., Fries L., Huemer H.P., Eisenberg R.J., Cohen G.H., Friedman H.M. : Herpes simplex virus glycoprotein C is a receptor for complement iC3b. J. Infect. Dis., 164 : 750-753, 1991.
PubMed
123) Friedman H.M., Cohen G.H., Eisenberg R.J., Seidel C.A., Cines D.B. : Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature, 309 : 633-635, 1984.
PubMed
124) Van Strijp J.A.G., Van Kessel K.P.M., Miltenburg L.A.M., Fluit A.C., Verhof J. : Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation. J. Virol., 62 : 847-850, 1988.
 
125) Huemer H.P., Burger R., Garred P., Cohen G., Eisenberg R., Friedman H., Esparza I., Dietrich M.P., Lambris J.D. : The interaction sites in C3b for HSV-1 gC and factor H are related. Complement Inflamm., 6 : 348-356, 1989.
 
126) Huemer H.P., Wang Y., Garred P., Koistien V., Oppermann S. : Herpes simplex virus glycoprotein C : molecular mimicry of complement regulatory proteins by a viral protein. Immunology, 79 : 639-647, 1993.
 
127) York I.A., Roop C., Andrews D.W., Riddell S.R., Graham F.L., Johnson D.C. : Acytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell, 77 : 525-535, 1994.
 
128) Hill A.B., Barnett B.C., McMichael A.J., McGeoch D.J. : HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol., 152 : 2736-2741, 1994.
 
129) Weinstein D.L., Walker D.G., Akiyama H., McGeer P.L. : Herpes simplex virus type 1 infection of the CNS induces major histocompatibility complex antigen expression on rat microglia. J. Neurosci. Res., 26 : 55-65, 1990.
 
130) Lewandowski G.A., Lo D., Bloom F.E. : Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1 : A possible mechanism of evasion of the immune response. Proc. Natl. Acad. Sci. USA, 90 : 2005-2009, 1993.
PubMed
131) Plaeger-Marshall S., Ank B.J., Altenburger K.M., Pizer L.I., Johnston R.B., Stiehm E.R. : Replication of herpes simplex virus in blood monocytes and placental macrophages from human neonates. Pediatr. Res., 26 : 135-139, 1989.
PubMed
132) Daniels C.A., Kleinerman E.S., Snyderman R. : Abortive and productive infections of human mononuclear phagocytes by type 1 herpes simplex virus. Am. J. Pathol., 91 : 119-136, 1978.
 
133) Hayward A.R., Read G.S., Cosyns M. : Herpes simplex virus interferes with monocyte accessorycell function. J. Immunol., 150 : 190-196, 1993.
 
134) Shelley W.B. : Herpes simplex virus as a cause of erythema multiforme. J. Am. Med. Assoc., 201 : 153-156, 1967.
 
135) Hayashi K., Yanagi K., Takagi S. : Clinical and experimental study of the immune complex (herpes simplex virus type 1-IgM) in herpes encephalitis patient's brain. J. Infect. Dis., 153 : 56-63, 1986.
 
136) Richardson W.P., Colvin R.B., Cheeseman S.H., Tolkoff-Rubin N.E, Herrin J.T., Cosimi A.B., Collins AB., Hirsch M.S., McCluskey R.T., Russell P.S., Rubin R.H. : Glomerulonephropathy associated with cytomegalovirus viremia in renal allografts. N. Engl. J. Med., 305 : 57-63, 1981.
 
137) Hendricks R.L., Tumpey T.M., Finnegan A. : IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J. Immunol., 149 : 3023-3028, 1992.
 
138) Staats H.F., Lausch R.N. : Cytokine expression in vivo during murine herpetic stromal keratitis : Effect of protective antibody therapy. J. Immunol., 151 : 277-283, 1993.
PubMed
139) Ido S., Siragenian R.P., Notkins A.L. : Cell-bound and circulating IgE antibody to herpes simplex virus. J. Gen Virol., 64 : 533-537, 1983.
 
140) Ikemoto K., Pollard R.B., Fukumoto T., Morimatsu M., Suzuki F. : Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J. Immunol., 155 : 1326-1333, 1995.
PubMed
141) Mercadal C.M., Bouley D.M., Destephano D., Rouse B.T. : Herpetic stromal keratitis in the reconstituted scid mouse model. J. Virol., 67 : 3404-3408, 1993.
 
142) Metcalf J.F., Kaufman H.E. : Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am. J. Ophthalmol., 82 : 827-834, 1976.
PubMed
143) Metcalf J.F., Hamilton D.S., Reichert R.W. : Herpetic keratitis in athymic (nude) mice. Infect.Immun., 26 : 1164-1171, 1979.
PubMed
144) Meyers-Elliot R.H., Chitjian P. : Immunopathogenesis of corneal inflammation in herpes simplex virus stromal keratitis : role of the polymorphonuclear leukocytes. Invest. Ophthalmol. Vis. Sci., 20 : 1784-1798, 1981.
 
145) Meyers-Elliot R.H., Chitjian P. : Immunology of herpesvirus infection : immunity to herpes simplex virus in eye infections. Surv. Ophthalmol., 21 : 194-204, 1976.
 
146) Kazmierowski J.A., Peizner D.S., Wueppner K.D. : Herpes simplex antigen in immune complexes of patients with erythema multiform : presence following recurrent herpes simplex infection. J.Am. Med., Assoc., 247 : 2547-2550, 1982.
 
147) Hayashi K., Iwasaki Y., Yanagi K. : Herpes simplex type 1-induced hydrocephalus in mice. J.Virol, 53 : 942-951, 1986.
 
148) Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., Alford C.A. : The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med., 326 : 663-667, 1992.
PubMed
149) Gallant J.E, Moore R.D., Richman D.D., Keruly J., Chaisson R.E. : Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J. Infect. Dis., 166 : 1223-1227, 1992.
PubMed
150) Holland G.N., Sison R.F., Jatulis D.E., Haslop M.G., Sakamoto M.J., Wheeler N.C. : Survival of patients with the acquired immunedeficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy study group Ophthalmology, 97 : 204-211, 1990.
 
151) Numazaki Y., Yano N., Morizuka T., Takai S., Ishida N. : Primary infection with human cytomegalovirus : virus isolation from healthy infants and pregnant women. Am. J. Epidemiol., 91 : 410-417, 1970.
PubMed
152) Collier A.C., Handsfield H., Ashley R., Roberts P.L., DeRouen T., Meyers J.D., Corey L. : Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J. Infect. Dis., 171 : 33-38, 1995.
 
153) Lang D.J., Kummor J.F. : Cytomegalovirus in semen : observations in selected populations. J.Infect. Dis., 132 : 472-473, 1975.
 
154) Detels R., Leach C.T., Hennessey K., Liu Z., Visscher B.R., Cherry J.D., Giorgi J.V. : Persistent cytomegalovirus infection of semen increases risk of AIDS. J. Infect. Dis., 169 : 766-768, 1994.
PubMed
155) Ho M. : Cytomegalovirus biology and infection. 2nd ed. Plenum, N.Y.
 
156) Bensun J.D., Huang E.S. : Human cytomegalovirus induces expression of cellular topoisomerase II. J. Virol., 64 : 9-15, 1990.
 
157) Dudding L., Haskill S., Clark B.D., Auron P.E., Sporn S., Huang E.S. : cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. J. Immunol., 143 : 3343-3352, 1989.
 
158) Estes J.E., Huang E.S. : Stimulation of cellular thymidine kinases by human cytomegalovirus. J. Virol., 24 : 13-21, 1977.
PubMed
159) Huang E.S. : Human cytomegalovirus : III Virus-induced DNA polymerase. J. Virol., 16 : 298-310, 1975.
PubMed
160) Bolodogh I., AbuBakar S., Albrecht T. : Activation of proto-oncogenes : an immediate early event in human cytomegalovirus infection. Science, 247 : 561-564, 1990.
PubMed
161) Hagemeier C., Walker S., Cuswell R., Kouzarides T., Sinclair J. : The human cytomegalovirus 80 kilodalton but not the 72 kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J. Virol., 66 : 4452-4456, 1992.
 
162) Santomenna L.D., Colberg-Poley A.M. : Induction of cellular hsp 70 expression by human cytomegalovirus. J. Virol., 64 : 2033-2040, 1990.
PubMed
163) Beck S., Barrell B.G. : Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature, 331 : 269-272, 1988.
PubMed
164) Browne H., Smith G., Beck S., Mirson T. : A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature, 347 : 770-772, 1990.
 
165) Browne H., Churcher M., Minson T. : Construction and characterization of human cytomegalovirus mutant with the UL18 (class I homologue) deleted. J. Virol., 66 : 6784-6787, 1992.
 
166) Chee M.S., Satchwell S.C., Preddie E., Weston K.M., Barrell B.G. : Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature, 344 : 774-777, 1990.
PubMed
167) Beck S., Barrell B.G. : An HCMV reading frame which has similarity with both the V and C regions of the TCR gamma chain. DNA Seq., 2 : 33-38, 1991.
 
168) Marniug W.C., Stoddart C.A., Lagenaur L.A., Abenes G.B., Mocarski E.S. : Cytomegalovirus determinant of replication in salivary glands. J. Virol., 66 : 3794-3802, 1992.
 
169) Britt W.J., Vugler L., Butfiloski E.J., Stephens E.B. : Cell surface expression of human cytomegalovirus (HCMV) gp 55-116 (gB) : use of HCMV-vaccinia recombinant virus infected cells in analysis of the human neutralizing antibody response. J. Virol., 64 : 1079-1085, 1990
 
170) Qadri I., Navarro D., Paz P., Pereira L. : Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J. Gen. Virol., 73 : 2913-2921, 1992.
PubMed
171) Simpson J.A., Chow J.C., Baker J., Audalovic N, Yuan S., Au D., Co M.S., Vasquez M., Britt W.J., Coelingh K.L. : Neutralizing monoclonal antibodies that distinguish three antigenic sites on the human cytomegalovirus glycoprotein H have conformationally-distract binding sites. J. Virol., 67 : 489-496, 1993.
 
172) Britt W.J., Auger D. : Identification of a 65,000 dalton virion envelope of human cytomegalovirus. Virus Res., 4 : 31-36, 1985.
PubMed
173) Winston D.J., Pollard R.B., Ho W.G., Gallagher J.G., Rasmussen L.E., Huang S.N., Lin C.H., Gossett T.G., Merigan T.C., Gale R.P. : Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann. Intern. Med., 97 : 11-18, 1982.
PubMed
174) Yeager A.S., Grumet F.C., Hafleigh E.B., Arvin A.M., Bradley J.E., Prober C.G. : Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J. Pediatr., 988 : 281-287, 1981.
 
175) Scalzo A.A., Fitzgerald NA., Simmons A., La Vista AB., Shellam G.R. : Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med., 171 : 1469-1483, 1990.
PubMed
176) Escudier E., Fleury J., Cordonnier C., Vernant J., Bornaudin J. : Large granular lymphocytes in bronchoalveolar lavage fluids from immunocompromised patients with cytomegalovirus pneumonitis. Am. J. Clin. Pathol., 86 : 641-645, 1986.
PubMed
177) Biron C.A., Byron K.S., Sullivan J.L. : Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med., 320 : 1731-1735, 1989.
 
178) Lucin P., Pavic I., Polic B., Jonic S., Koszinowski U.H. : Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol., 66 : 1977-1984, 1992
 
179) del Val M., Volkmer H., Rothbard J.B., Jonjic S., Messerle M., Schickedauz J., Reddehase M.J., Koszinowski U.H. : Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J. Virol., 62 : 3965-3972, 1988.
PubMed
180) Koszinowski U.H., del Val M., Reddehase M.J. : Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr. Top. Microbiol. Immunol., 154 : 189-220, 1990.
PubMed
181) Alp N.J., Allport T.D., Zanten J.V., Rodgers B., Sissons J.G.P., Borysiewicz L.K. : Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early I protein. J.Virol., 65 : 4812-4820, 1991.
 
182) Riddell S.R., Rabin M., Geballe A.P., Britt W.J., Greenberg P.D. : Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not requireendogenous viral gene expression. J. Immunol., 46 : 2795-2804, 1991.
PubMed
183) Borysiewicz L.K., Hickling J.K., Graham S., Sinclair J., Cranage M.P., Smith G.L., Sissons J.G.P. : Human cytomegalovirus-specific cytotoxic T cells : relative frequency of state-specific CTL recognizing the 72-KD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med., 168 : 919-931, 1988.
 
184) He H., Rinaldo C.R, Morel P.A. : Immunogenetics of the human T cell response to HCMV. In : Multidisciplinary approach to understanding cytomegalovirus disease (ed. by Michelson S., Plotkin S.A.), Amsterdam, Excerpta Medica, 1993, pp. 333-337.
 
185) Gilbert M.J., Riddell S.R., Li C.-R., Greenberg P.D. : Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J. Virol., 67 : 3461-3469, 1993.
 
186) del Val M., Hengel H., Hacher H., Hartlaub U., Ruppert T., Lucin P., Koszinowski U.H. : Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med., 176 : 729-738, 1992.
 
187) Grundy J.E, Lui S.F., Super M., Berry N.J., Sweny P., Fernando Q.N., Moorhead J., Griffiths P.D. : Symptomatic cytomegalovirus infection in seropositive kidney recipients : reinfection with donor virus rather than reactivation of recipient virus. Lancet, 16 : 132-135, 1988.
 
188) Hayashi K., Saze D., Uchida Y. : Studies of latent cytomegalovirus infection : The macrophagesas virus-harboring cell. Microbiology and Immunol., 29 : 625-634, 1985.
 
189) Brautigam A.R, Dutko F.J., Olding L.B., Oldstone M.B. : Pathogenosis of murine cytomegalovirus infection : the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J. Gen. Virol., 44 : 349-359, 1979.
 
190) Pomeroy C., Hilleren P.J., Jordan M.C. : Latent cytomegalovirus DNA in splenic stromal cells of mice. J. Virol., 65 : 330-334, 1991.
 
191) Klotman M.E., Henry S.C., Greene R.C., Brazy P.C., Klotman P.E., Hamilton J.D. : Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J.Infect. Dis., 161 : 220-225, 1990.
PubMed
192) Mocarsky E.S., Abenes G.B., Mauning W.C., Sambucetti L.C., Cherrington J.M. : Moleculargenetic analysis of cytomegalovirus gene regulation in growth, persistence and latency. Curr. Top. Microbiol. Immunol., 154 : 47-74, 1990.
 
193) Epstein M.A., Achong B.G., Barr Y.M. : Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet, 1 : 252-253, 1964.
 
194) Henle G., Henle W., Clifford P., Diehl V., Kafuko G.W., Kirya B.G., Klein G., Morrow R.H., Munube G.M.R., Piko P., Tukei D.M., Ziegler J.L. : Antibodies to EB virus in Burkitt's lymphoma and control groups. J. Natl. Cancer Inst., 43 : 1147-1157, 1969.
 
195) Sixbey J.W., Nedrud J.G., Raab-Traub N., Hanes R.A., Pagano J.S. : Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med., 310 : 1225-1230, 1984.
PubMed
196) Wolf H., zur Hausen H., Becker V. : Persistence of EB virus in the parotid gland. J. Virol., 51 : 795-798, 1984.
 
197) Niedobitek G., Herbst H., Young L.S., Brooks L., Masucci M.G., Crocker J., Rickinson A.B., Steiu H. : Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood, 79 : 2520-2526, 1992.
 
198) Henle G., Henle W. : The virus as the etiologic agent of infectious mononucleosis. In : The Epstein-Barr Virus (ed. by Epstein M.A., Achong B.G.), Springer-Verlag, Berlin, 1979, pp. 297-320.
 
199) Pearson G.R., Qualtiare L.F., Klein G., Norin T., Bal I.S. : Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt lymphoma. Int. J. Cancer, 24 : 402-406, 1979.
 
200) Sixbey J.W., Yao Q.Y. : Immunoglobulin A-induced shifts of Epstein-Barr virus tissue tropism. Science, 255 : 1578-1580, 1992.
PubMed
201) Henle W., Henle G., Andersson J., Ernberg I., Klein G., Horwitz C.A., Marklund G., Rymo L., Wellinder C., Straus S.E. : Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc. Natl. Acad. Sci. USA, 84 : 570-574, 1987.
PubMed
202) Gan Y.-J., Sullivan J.L., Sixbey J.W. : Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J. Infect. Dis., 170 : 436-439, 1994.
PubMed
203) Garzeli C., Jaub F.E., Schaff J.E., Prabhakar B.S., Ginsberg-Fellner F., Notkins A.L. : Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigensin multiple organs. J. Virol., 52 : 722-725, 1984.
 
204) Rousset F., Gavcia E., Defrance T., Peronne C., Vezzio N, Hsu D.-H., Kastelein R., Moore K.W., Banchereau J. : Interleukin 1O is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA, 89 : 1890-1893, 1992.
 
205) Sheldon P.J., Papamichail M., Hemsted E.H., Holborow E.J. : Thymic origin of atypical lymphoidcells in infectious mononucleosis. Lancet, 1 : 1153-1155, 1973.
 
206) Reinherz E.L, O'Brien C., Rosenthal P., Schlossman S.F. : The cellular basis for viral-induced immunodeficiency : analysis by monoclonal antibodies. J. Immunol., 125 : 1269-1274, 1980.
PubMed
207) Strang G., Rickinson A.B. : In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients. Immunology, 62 : 647-654, 1987
PubMed
208) Strang G., Rickinson A.B. : Multiple HLA class I-dependent cytotoxicities constitute the non-HLA-restricted response in infectious mononucleosis. Eur. J. Immunol., 17 : 1007-1013, 1987.
 
209) Svedmyr E., Jondal M. : Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc. Natl. Acad. Sci. USA, 72 : 1622-1626, 1975.
PubMed
210) Tomkinson B.E., Maziarz R., Sullivan J.L. : Characterization of the T cell mediated cellular cytotoxicity during acute infectious mononucleosis. J. Immunol., 143 : 660-670, 1989.
 
211) Robinson J.E., Smith D., Niederman J. : Plasmacytic differentiation of circulating Epstein-Barrvirus infected B lymphocytes during acute infectious mononucleosis. J. Exp. Med., 15 : 235-244, 1981.
 
212) Yao Q.Y., Rickinson A.B., Epstein M.A. : A re-examination of the Epstein-Barr virus carrierstate in healthy seropositive individuals. Int. J. Cancer, 35 : 35-42, 1985.
 
213) Yao Q.Y., Czernecka H., Rickinson A.B. : Spontaneous outgrowth of Epstein-Barr virus-positive-B-cell line from circulating human B cells of different buoyant densities. Int. J. Cancer, 48 : 253-257, 1991.
 
214) Rickinson A.B. : Cellular immunological responses to infection by the virus. In : The Epstein-Barr virus : recent advances (ed. by Epstein M.A., Achong B.G.), William Heineman, London, 1986, pp. 75-125.
 
215) Rickinson A.B., Moss D.J., Wallace L.E., Misko J.H., Epstein M.A., Pope J.H. : Long-term T cell-mediated immunity to Epstein-Barr virus. Cancer Res., 41 : 4216-4221, 1981.
 
216) Misko I.S., Kane R.G., Pope J.H. : Generation in vitro of HLA-restricted EB virus-specific cytotoxic human T cells by autologous lymphoblastoid cell lines : the roles of previous EB virus infection and foetal calf serum. Int. J. Cancer, 29 : 41-48, 1982.
 
217) Khanna R., Burrows S.R., Kurilla M.G., Jacob C.A., Misko I.S., Scully T.B., Kieff E, Moss D.J. : Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia : implications for vaccine development. J. Exp. Med., 176 : 169-176, 1992.
 
218) Murray R.J., Kurilla M.G., Brooks J.M., Thomas W.A., Rowe M., Kieff E., Rickinson A.B. : Identification of target antigens for human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies. J. Exp. Med., 176 : 157-168, 1992.
PubMed
219) Sample J., Young L., Martin B., Chatman T., Kieff E., Rickinson A., Kief E. : Epstein-Barr virus type 1 (EBV-1) and 2 (EBV-2) differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J. Virol., 64 : 4084-4092, 1990.
 
220) Moss D.J., Misko I.S., Burrows S.R., Burman K., McCarthy R., Sculley T.B. : Cytotoxic Tcell clones discriminate between A and B type Epstein-Barr virus transformarts. Nature, 331 : 719-721, 1988.
 
221) Burrows S.R., Sculley T.B., Misko I.S., Schmidt C., Moss D.J. : An Epstein-Barr virus-specific cytotoxic Tcell epitope in EBNA3. J. Exp. Med., 171 : 345-350, 1990.
 
222) Gavioli R., Kurilla M.G., de Compos-Lima P.-O., Wallace L.E., Dolcetti R., Murray R.J., Rickinson A.B., Masucci M.G. : Multiple HLA-A11-restricted cytotoxic T-lymphacytes epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67 : 1572-1578, 1992.
 
223) de Campos-Lima P.-O., Gaviol R., Zhang Q.L., Wallace L.E., Dolcetti R., Rowe M., Rickinson A.B., Masucci M.G. : HLA-A11 epitope loss isolates of Epstein-Barr virus from highly A11+-population. Science, 260 : 98-100, 1993.
 
224) de Campos-Lima P.-O., Lovitsky V., Brooks J., Lee S.P., Hu L.F., Rickinson A.B., Masucci M.G. : T cell responses and virus evolution : loss of HLA A11-restricted CTL epitopes in Epstein-Barrvirus isolates, from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med., 179 : 1297-1305, 1994.
 
225) Adams A., Lindahl T. : Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc. Natl. Acad. Sci. USA, 72 : 1477-1481, 1975.
PubMed
226) Sugden B., Marsh K., Yates J. : A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol. Cell Biol., 5 : 410-413, 1985.
 
227) Tanaka O., Nonoyama M. : Latent DNA of Epstein-Barr virus. Separation from high molecularweight cell DNA in a neutral glycerol gradient. Proc. Natl. Acad. Sci. USA, 11 : 4658-4661, 1974.
 
228) Hendorson A., Ripley S., Heller M., Kieff E. : Human chromosome association of Epstein-Barrvirus DNA in a Burkitt tumor cell line and in lymphocytes growth transformed in vitro. Proc. Natl. Acad. Sci. USA, 80 : 1987-1991, 1983.
 
229) Weigel R., Fischer D.K., Heston L., Miller G. : Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication. J. Virol., 125 : 287-298, 1983.
 
230) Kerr B.M., Lear A.L., Rowe M., Croom-Carter D., Young L.S., Rookes S.M., Gallimore P.H., Rickinson A.B. : Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids : cell phenotype. dependence of virus promotor usage. Virology, 187 : 189-201, 1992.
 
231) Contreras-Brodin B.A., Anvret M., Imreh S., Altiok E., Klein G., Masucci M., : B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6 : studies with somatic cell hybrids. J. Gen. Virol., 72 : 3025-3033, 1991.
PubMed
232) Clemons M.J. : The small RNAs of Epstein-Barr virus. Mol. Biol. Reports, 17 : 81-92, 1993.
 
233) Gregory C.D., Edwards C.F., Milner A., Wiels J., Lipinski M., Rowe M., Tursz T., Rickinson A.B. : Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus. Int. J. Cancer, 42 : 213-220, 1988.
PubMed
234) Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. : Induction of bc1-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65 : 1107-1115, 1991.
 
235) Rowe M., Lear A., Croom-Carter D., Davis A.H., Rickinson A.B. : Three pathways of Epstein-Barr virus gene activation from EBNA 1 positive latency in B lymphocytes. J. Virol., 66 : 122-131, 1992.
 
236) Masucci M.G., Torsteinsdottir S., Colonbani J., Brautbar C., Klein E., Klein G., : Down regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma line. Proc. Natl. Acad. Sci. USA, 84 : 4567-4571, 1987.
 
237) Torsteinsdottir S., Brautbar G., Klein G., Klein E., Masucci M.G. : Differential expression of HLA antigens on human B-cell lines of normal and malignant origin : a consequence of immune surveillance or a phenotype vestige of the progenitor cells? Int. J. Cancer, 41 : 913-919, 1988.
PubMed
238) de Waal Malefyt R, Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., d Vries J.E. : Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminising the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expresson. J. Exp. Med., 174 : 915-924, 1991.
 
239) Gregory C.P., Murray R., Edwards C.F., Rickinson A.B. : Down regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor escape from virus specific T cell surveillance. J. Exp. Med., 167 : 1811-1824, 1988.
 
240) Moore K., Vieira P., Fiorentino D., Tronstine M.L., Khan T.A., Mosmann T.R. : Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF. Science, 248 : 1230-1234, 1990.
 
241) Fiorentino D., Bond M., Mosmann T. : Two types of murine helper T cell clone IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 170 : 2081-2095, 1989.
PubMed
P.75 掲載の参考文献
1) 橋戸円, 川名尚, 津上久弥, 他 : 我が国における単純ヘルペスウイルス2型特異抗体の保有状況. 医学のあゆみ, 152 : 669-670, 1990.
 
2) 鳥羽和憲 : 血清疫学の面から. ヘルペスウイルス感染症(森良一, 川名尚編). メディカルトリビューン, 1986, pp. 161-172.
 
3) 川名尚, 橋戸円 : 微量中和法による型別抗単純ヘルペスウイルス抗体測定法の評価.臨床とウイルス, 19 : 347-351, 1991.
Medical*Online
4) 橋戸円, 川名尚, 鈴木理恵子, 他 : 一般成人における抗単純ヘルペスウイルスIgG ; IgA, IgM抗体のELISA法による検討.臨床とウイルス, 17 : 391-396, 1989.
Medical*Online
5) Hashido M., Kawana T., Inouye S. : Differentiation of primary from nonprimary genital herpesvirus infections by detection of polymeric immunoglobulin A activity. J Clin. Microbiol, 27 : 2609-2611, 1989.
PubMed
6) 橋戸円, 川名尚, 井上栄 : 血中ポリマーIgA抗体の検出による単純ヘルペスウイルス初感染と再発の鑑別-連鎖球菌菌体によるモノマーIgA抗体の吸収-. 感染症誌, 66 : 225-231, 1992.
 
7) Whitley R. J., Lakeman F. : Herpes simplex virus infections of the central nervous system : Therapeutic and diagnostic considerations. Clin. Infect. Dis., 20 : 414-420, 1995.
PubMed
8) Kawana T., Hashido M., Koizumi Y. : Class-specific antibody response in acyclovir-treated and adenine arabinoside-treated patients with primary genital herpes simplex virus infection. Microbiol. Immunol., 39 : 795-799, 1995.
PubMed
9) Lee F. K., Coleman R.M., Pereira L., et al. : Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J. Clin. Microbiol, 22 : 641-644, 1985.
 
10)Ashley R. L., Militoni J., Lee F.K., et al. : Comparison of western blot and glycoprotein G-specific immunodot enzyme assay for detecting HSV-1 and HSV-2 antibodies in human sera. J. Clin. Microbiol., 26 : 662-667, 1988.
 
11) Ashley R., Cent A., Maggs V., et al. : Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann. Intern. Med., 115 : 520-526, 1991.
PubMed
12) 高山道子 : 免疫学的検査, ウイルス感染症関連検査, 水痘・帯状疱疹ウイルス. 日本臨床, 53 : 255-257, 1995.
 
13) 沼崎義夫 : ヘルペスウイルス群感染症, 抗原・抗体の免疫学的検査法の進歩, サイトメガロウイルス. 日本臨床, 47 : 361-366, 1989.
 
14) Weber B., Doerr H. W. : Diagnosis and epidemiology of transfusion-associated human cytomegalovirus infection : Recent developments. Infusionsther. Transfusionsmed., 21 : 32-39, 1994.
PubMed
15) Rasmussen L. : Immune response to human cytomegalovirus infection. CTMI, 154 : 221-254, 1990.
 
16) 水野文雄 : 免疫学的検査, ウイルス感染症関連検査, EBウイルス. 日本臨床, 53 : 261-264, 1995.
 
17) 多屋馨子, 山西弘一 : ウイルス検査法, 小児感染症, 突発性発疹. 臨床とウイルス, 23 : 89-94, 1995.
 
P.85 掲載の参考文献
1) Hondo R., Yogo Y., Kurata T., et al. : Genome variation among varisella-zoster virus isolates derived from different individuals and from the same individuals. Arch. Virol., 93 : 1-12, 1987.
PubMed
2) Hondo R., Yogo Y., Kurata T., et al. : Detection of varicella-zoster virus DNA in cultured cells and tissue specimens by in situ hybridization using biotin-labeled probes. Jpn. J. Exp. Med., 57 : 339-346, 1987.
PubMed
3) Hondo R., Ito S., Inouye S. : Titration of varicella-zoster virus DNA in throat swabs from varicella patients by combined use of PCR and microplate hybridization. Jpn. J. Med. Sci. Biol., 48 : 249-255, 1995.
PubMed
4) Hondo R., Yogo Y. : Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA. J. Virol., 62 : 2916-2921, 1988.
 
5) Hondo R., Yogo Y., Yoshida M., et al. : Distribution of varicella-zoster virus strains carrying a Pst I-site-less mutation in Japan and DNA change responsible for the mutation. JPn. J. Exp. Med., 59 : 233-237, 1989.
 
6) Inouye S., Hondo R. : Microplate hybridization of amplified viral DNA segment. J. Clin. Microbiol., 28 : 1469-1472, 1990.
PubMed
P.93 掲載の参考文献
1) Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. : ldentification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266 : 1865-1869,1994.
 
2) Pastuszak A. L., Levy M., Schick B., Zuber C., Feldkamp M., Gladstone J., Bar-Levy F., Jackson E, Donnenfeld A., Meschino W. : Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N. Engl. J. Med., 330 : 901-905, 1994.
PubMed
3) Muraki R., Baba T., Iwasaki T., Sata T., Kurata T. : Immunohistochemical study of skin lesions in herpes zoster. Virchows Archiv. A Pathol. Anat., 420 : 71-76, 1992.
PubMed
4) 佐多徹太郎, 倉田毅 : II. ウイルス病理学的診断. 水痘・帯状疱疹(高橋理明, 新村眞人編), メディカルトリビューン, 1987, pp. 44-54.
 
5) 浜崎豊 : 先天性サイトメガロウイルス感染症. 病理と臨床, 3 : 504-508, 1985.
 
6) Iwasaki T. : Alimentary tract lesions in cytomegalovirus infection. Acta. Pathol. Jpn., 37 : 549-565, 1987.
PubMed
7) Tokunaga M., Uemura Y., Tokudome T., Ishidate T., Masuda H., Okazaki E., Kaneko K., Naoe S., Ito M., Okamura A., Shimada A., Sato E., Land C.E. : Epstein-Barr virus related gastric cancer in Japan. : A molecular patho-epidemiological study. Acta. Pathol. Jpn., 43 : 574-581, 1993.
 
8) Thomas J.A., Felix D.H., Wray D., et al. : Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am. J. Pathol., 139 : 1369-1380, 1991.
PubMed
9) 佐多徹太郎 : KSHVとHHV8. 医学のあゆみ, 1996, 印刷中
 
10) Boshoff C., Shulz T.F., Kennedy M.M., Graham A., Fisher C., Thomas A., McGee J.O., Weiss R.A., 0'Leary J.J. : Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med., 1 : 1274-1278, 1995.
 
P.99 掲載の参考文献
1) Prusoff W. H. : Idoxuridine or how it all began. In : Clinical Use of Antiviral Drugs (ed. by De Clercq E.), Martinus Nijhoff Publishing, Boston, Dondrecht, Lancaster, 1988, pp. 15-24.
 
2) Wellings P. C., Audry P.N., Bors P.H., et al. : Clinical evaluation of trifluorothymidine in the treatment of human herpes simplex corneal ulcers. A. J. Ophthalmol., 73 : 932-942, 1972.
 
3) Whitley R. J., Ch'ien L.T., Dolin R., et al. : Adenine arabinoside therapy of herpes zoster in the immunocompromised. N. Engl. J. Med., 294 : 1193-1199, 1976.
PubMed
4) Whitley R. J., Alford C.A., Hirsh M.S., et al. : Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med., 314 : 144-149, 1986.
 
5) Elion G. B., Furmann P.A., de Milanda P., et al. : Selectivity of action of antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. USA, 74 : 5716-5720, 1977.
 
6) Kimberlin D. W., Coen D.M., Biron K.K., et al. : Molecular mechanisms of antiviral resistance. Antivir. Res., 26 : 369-401, 1995.
PubMed
7) 茂田士郎, 他 : 抗ウイルス薬の進歩.日本医事新報, 3730 : 26-30, 1995.
Medical*Online
8) Birch C.J., Tyssen D.P., Tachedjian G., et al. : Clinical effects and in vitro studies of trifluorothymidine combined with interferon α for treatment of drug resistant and sensitive herpes simplex infections. J. Infect. Dis., 166 : 108-112, 1992.
 
9) Chou S., Erice A., Colin M., et al. : Analysis of the UL97 phosphotransferase coding in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis., 171 : 576-583, 1995.
 
10) Beutner K.R. : Valacyclovir : a review of its antiviral activity, pharmacokinetics, and clinical efficacy. Antivir. Res., 28 : 281-290, 1995.
PubMed
11) Pue M.A., Benez Z. : Pharmacokinetics of famiciclovir in man. Antivir. Chem. Chemother., 4(Suppl.1) : 47-55, 1993.
 
12) Neyts J., Snoeck D., Schols J., et al. : Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine[(S)-HPMPC]and 9-(1, 3-dihydroxy-2-propoxymethyl) guanine (DHPG). Virology, 179 : 41-50, 1990.
 
13) Omar R.F., Dusserre N., Desorneaux A, et al. : Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet. Antimicrob. Agents Chemother., 39 : 1973-1978, 1995.
PubMed
14) Neyts J, Andrei G., Snoeck R., et al. : The N-substituted acyclic nucleoside analog 2-amino-7 (1, 3-dihydroxy-2-propoxy) methyl purine is a potent and selective inhibitor of herpesvirus replication. Antimicrob. Agents Chemother., 38 : 2710-2716, 1994.
 
15) O'Hara P. : Targets for antiviral chemotherapy : herpes simplex virus regulating protein, Vmw65. Antivir. Chem. Chemother., 2 : 1-7, 1991.
 
P.106 掲載の参考文献
1) Mocarski E.S. : Cytomegaloviruses and their replication. In : Fields Virology, 3rd ed.(ed. by Fields B.N, Knipe D.M., Howley P.M.), Lippincott-Raven Publishers, Philadelphia, 1996, pp. 2447-2492.
 
2) Compton T. : Towards a definition of HCMV entry pathway. Scand. J. Infect. Dis., 99(Suppl.) : 30-32, 1995.
 
3) 南嶋洋一 : サイトメガロウイルス.最新内科学大系26 : ウイルス感染症(井村裕夫, 尾形悦郎, 高久史麿, 垂井清一郎編.齋藤厚, 島田馨専門編集), 中山書店, 1994, pp. 147-154.
 
4) 南嶋洋一 : 移植とサイトメガロウイルス.今日の移植, 4 : 483-487, 1991.
 
5) 南嶋洋一, 峰松俊夫 : ウイルス検査法-サイトメガロウイルス.臨床とウイルス, 23(Suppl.) : 131-136, 1995.
 
6) 峰松俊夫, 細田健治, 南嶋洋一 : 抗サイトメガロウイルス・ヒトモノクローナル抗体F(ab')2分画を用いた直接免疫ペルオキシダーゼ法による抗原陽性白血球検出法の基礎的検討. 感染症誌, 68 : 1278-1283, 1994.
 
7) The T.H., van der Bij W., van der Berg A.P., van der Giessen M., Weits J., Sprenger H.G., van Son W.J. : Cytomegalovirus antigenemia. Rev. Inf. Dis., 12 : S737-S744, 1990.
 
P.112 掲載の参考文献
1) Epstein M.A., Achong B. G. : The Epstein-Barr virus. Springer-Verlag, New York, 1979.
 
2) Kieff E. : Epstein-Barr virus and its replication. In : Virology, Third ed. (ed.by Fields B. N, Knipe D.M., Howley P. M.), Raven Press, New York, 1996, pp. 2343-2396.
 
3) Rickinson A. B., Kieff E. : Epstein-Barr virus. In : Virology, Third ed. (ed. by Fields B. N., Knipe D.M., Howley P. M.), Raven Press, New York, 1996, pp. 2397-2446.
 
P.120 掲載の参考文献
1) Salahuddin S.Z., Ablashi D.V., Markham P.D., et al. : Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science, 234 : 596-601, 1986.
PubMed
2) Yamanishi K., Okuno T., Shiraki K., et al. : Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet, 1 : 1065-1067, 1988.
PubMed
3) Frenkel N., Schirmer E.C., Wyatt L.S., et al. : Isolation of a new herpesvirus from human CD4+ T cells. Proc. Natl. Acad. Sci. USA, 87 : 748-752, 1990.
PubMed
4) Chang Y., Cesarman E., Pessin M.S., et al. : Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266 : 1865-1869, 1994.
PubMed
5) Gompels U.A., Nicholas J., Lawrence G., et al. : The DNA sequence of human herpesvirus-6 : structure, coding content, and genome evolution. Virology, 209 : 29-51, 1995.
 
6) Kishi M., Harada H., Takahashi M., et al. : A repeat sequence, GGGTTA, is shared by DNA of human herpesvirus 6 and Marek's disease virus. J. Virol., 62 : 4824-4827, 1988.
 
7) Thomson B.J., Efstathiou S., Honess R.W. : Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature, 351 : 78-80, 1991.
PubMed
8) Inoue N, Dambaugh T.R., Rapp J.C., et al. : Alphaherpesvirus origin-binding protein homologue encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that are similar to ori regions of alphaherpesviruses. J. Virol., 68 : 4126-4136, 1994.
 
9) Kondo K., Kondo T., Okuno T., et al. : Latent human herpesvirus 6 infection of human monocytes/macrophages. J. Gen. Virol., 72 : 1401-1408, 1991.
PubMed
10) Lusso P., Malnati M.S., Garzino-Demo A., et al. : Infection of natural killer cells by human herpesvirus 6. Nature, 362 : 458-462, 1993.
PubMed
11) He J., McCarthy M., Zhou Y., et al. : Infection of primary human fetal astrocytes by human herpesvirus 6. J. Virol., 70 : 1296-1300, 1996.
PubMed
12) Inagi R., Guntapong R., Nakao M., et al. : Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2. J. Med. Virol., in press, 1996.
 
13) Lusso P., Secchiero P., Crowley R.W., et al. : CD4 is a critical component of the receptor for human herpesvirus 7 : interference with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA, 91 : 3872-3876, 1994.
PubMed
14) Kondo K., Kaneshima H., Mocarski E.S. : Human cytomegalovirus latent infection of granulocytemacrophage progenitors. Proc. Natl. Acad. Sci. USA, 91 : 11879-11883, 1994.
PubMed
15) Kondo K., Nagafuji H., Hata A., et al. : Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J. Infect. Dis., 167 : 1197-1200, 1993.
PubMed
16) Lisitsyn N., Lisisyn N., Wigler M. : Cloning the differences between two complex genomes. Science, 259 : 946-951, 1993.
 
17) Huang Y.Q., Kaplan J.J., Li M.H., et al. : Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet, 345 : 759-761, 1995.
 
18) Cesarman E., Chang Y., Moore P.S., et al. : Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med., 332 : 1186-1191, 1995.
PubMed
19) Gessain A., Sudaka A., Briere J., et al. : Kaposi's sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease : Is there any relevant association in non-human immunodeficiency virus-infected patients? Blood, 87 : 414-416, 1996.
 
20) Rady P.L, Yen A., Rollefson J.L., et al. : Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet, 345 : 1339-1340, 1995.
PubMed
21) Ambroziak J.A., Blackbourn D.J., Herndier B.G., et al. : Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science, 268 : 582-583, 1995.
PubMed
22) Lin J.C., Lin S.C., Mar E.C., et al. : Is Kaposi's-sarcoma associated herpesvirus detected in semen of HIV-infected homosexual men? Lancet, 346 : 1601-1602, 1995.
PubMed
23) Bigoni B., Dolcetti R., Lellis L, et al. : Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J. Infect. Dis., 173 : 542-549, 1996.
PubMed
24) Monini P., Lellis L, Fabris M., et al. : Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N. Engl. J. Med., 334 : 1168-1172, 1996.
 
25) Renne R., Zhong W., Herndier B., et al. : Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med., 2 : 342-346, 1996.
PubMed
26) Moore P., Gao S.J., Dominguez G., et al. : Primary characterization of herpesvirus agent associated with Kaposi's sarcoma. J.Virol., 70 : 549-558, 1996.
PubMed

II. 単純ヘルペスの臨床

P.132 掲載の参考文献
1) 川名尚, 本藤良 : 型特異抗体測定法. ヘルペスウイルス感染症(森良一, 川名尚編). メディカルトリビューン, 1986, pp. 65-77.
 
2) 和山行正, 原瑞枝, 中野百合香, 本藤良 : 単純ヘルペスI型・II型の血清疫学. 第40回日本ウイルス学会総会演説抄録, p.115, 1992.
 
3) 川名尚, 橋戸円 : 性器ヘルペスと血清抗体. 産婦人科の実際, 39 : 1717-1721, 1990.
 
4) 吉田正己 : 単純ヘルペス, 水痘・帯状疱疹-周辺疾患を含めて-. メディカルトリビューン, 1991, pp. 12-31.
 
5) 川名尚 : 女性性器ヘルペス. 最新医学, 44 : 39-45, 1989.
Medical*Online
6) 広瀬崇興 : 男性の性器ヘルペスの感染経路. ヘルペスの診療Q&A(新村眞人編). 臨床医薬研究協会, 1993, pp. 56-57.
 
7) Kameyama T., Sujaku C., Hwang C. B. C., Shillitoe E. J. : Shedding of herpes simplex virus type1 into saliva. J. Oral. Pathol., 17 : 478-481, 1988.
 
8) Vestey J. P., Norval M. : Mucocutaneous infections with herpes simplex virus and their management. Clin. Exp. Dermatol., 17 : 221-237, 1992.
PubMed
9) Kameyama T., Futami M., Nakayoshi N, Sujaku C., Yamamoto S. : Shedding of herpes simplex virus type 1 into saliva in patients with orofacial fracture. J. Med. Virol., 28 : 78-80, 1989.
PubMed
10) 吉田正己, 手塚正 : 生活用品または医療器具を介する単純ヘルペスの感染経路. 西日皮膚, 50 : 1050-1054, 1988.
 
11) 大木和, 本田まり子, 新村眞人 : 慈恵医大皮膚科における性器ヘルペス初感染者の統計. 第3回ヘルペスウイルス研究会プログラム抄録集, p.49, 1988.
 
12) 井上幸次 : 初感染ヘルペス. 眼とヘルペス(眞鍋禮三編). 医学書院, 1990, pp. 7-10.
 
13) 橋戸円, 川名尚, 井上栄 : 血中ポリマーIgA抗体の検出による単純ヘルペス初感染と再発の鑑別-連鎖球菌菌体によるモノマーIgA検体の吸収-. 感染症誌, 66 : 225-231, 1992.
 
14) 広瀬崇興 : 男性の性器ヘルペスの特徴. ヘルペスの診療Q&A(新村眞人編). 臨床医薬研究協会, 1993, pp. 54-55.
 
15) 下村嘉一 : 上皮型ヘルペス(epithelial herpes). 眼とヘルペス(眞鍋禮三編). 医学書院, 1990, pp. 14-17.
 
16) Uchio E., Hatano H., Mitsui K., Sugita M., Okada K., Goto K., Kagiya M., Enomoto Y., Ohno S. : A retrospective study of herpes simplex keratitis over the last 30years. Jpn. J. Ophthalmol., 38 : 196-201, 1994.
 
17) 森島恒雄 : 新生児HSV感染症におけるウイルス学的解析. 第2回ヘルペス感染症フォーラム抄録, p.41, 1995.
 
18) 高須俊明, 亀井聡, 田村英二, 土屋雅彰 : ヘルペス脳炎. 綜合臨床, 33 : 2451-2456, 1984.
 
19) 小野公義 : サーベイランスからみたカポジー水痘様発疹症の統計. 皮膚臨床, 37 : 1995-1998, 1995.
 
20) Andrew A., Hendricks M. D., Edward P., Shapiro M. D. : Primary herpes simplex infection following mouth-to-mouth resuscitation. JAMA, 243 : 257-258, 1980.
 
21) Perl T. M, Haugen T. H., Pfaller M. A., Hollis R., Lakeman A. D., Whilley R. J., Nicholson D., Hunter G. A., Wenzel R. P. : Transmission of herpes simplex virus type 1 infection in an intensive care unit. Ann. Intern. Med., 117 : 584-586, 1992.
 
22) 鳥羽和憲, 村林博志, 會田研二 : 単純ヘルペスウィルス1型の血清疫学-一般人, 医療従事者の抗体保有状況について-. 第33回日本ウイルス学会総会演説抄録, p.124, 1985.
 
23) Sakaoka H., Saheki Y., Uzuki K., Nakakita T., Saito H., Sekine K., Fujinaga K. : Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns. J. Clin. Microbiol., 24 : 36-40, 1986.
PubMed
24) 鳥羽和憲, 市川誠一, 會田研二 : 単純ヘルペスウイルス1型に対する感染機会に及ぼす同居家族の影響について. 第38回日本ウイルス学会総会演説抄録, p.241, 1990.
 
25) Mertz G. J., Coombs R. W., Ashley R, Jourden J., Remington M., Winter C., Fahnlander A., Guinan M., Ducey H., Corey L. : Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner : A prospective study. J. Infect. Dis., 157 : 1169-1177, 1988.
 
P.142 掲載の参考文献
1) 森良一, 川名尚(編) : ヘルペスウイルス感染症. メディカルトリビューン, 東京, 1986.
 
2) 日沼頼夫(編) : ウイルスの臨床検査. Mook 28. 金原出版, 東京, 1988.
 
3) 新村眞人(編) : ヘルペスの診療Q&A. 臨床医薬研究協会, 東京, 1993.
 
4) 郷路勉, 熊本悦明, 広瀬崇興, 他 : 男子単純性器ヘルペスの臨床的検討. 臨床皮膚科, 42 : 1025-1030, 1988.
 
5) 坂岡博, 上野哲治, 鈴木信敬, 他 : 制限酵素によるウイルス株同定法とそのmolecular epidemiology への応用. 医学のあゆみ, 125 : 867-877, 1983.
 
6) 坂岡博, 本多丘人, 斉藤仁, 他 : 制限酵素による単純ヘルペスウイルス1型再発株の解析. 臨床とウイルス, 12 : 310-316, 1984.
 
7) 坂岡博 : ヘルペスウイルス遺伝子の多様性とその疫学への応用 : 分子疫学. 最新医学, 44 : 18-23, 1989.
Medical*Online
8) 坂岡博, 藤永惠 : 感染症の分子疫学 -とくにヘルペスウイルス感染症について. 日本臨床, 増刊号 (DNA診断-分子生物学の臨床応用), 47 : 810-823, 1989.
 
9) 坂岡博, 栄鶴義人 : ゲノムの制限酵素切断法による種の同定と個体差の識別. 日本臨床, 特別号(感染症-遺伝子診断と分子疫学), 50 : 125-135, 1992.
 
10) 坂岡博, 栗田啓子, 出村守 : 単純ヘルペスウイルスのDNA診断法とその分子疫学・分子進化学への応用. 臨床とウイルス, 増刊号(ウイルス検査法), 23 : 120-125, 1995.
 
11) 坂岡博, 藤永惠(編) : 分子疫学 -ヘルペスからエイズまで. 共立出版, 東京, 1990.
 
12) 梅根健一 : ヘルペスウイルスのゲノム構造. 蛋白質 核酸 酵素, 37 : 2374-2378, 1992.
 
13) McGeoch D. J. : The genomes of the human herpesviruses : contents, relationships, and evolution. Ann. Rev. Microbiol., 43 : 235-265, 1989
 
14) Nei M. : Molecular evolutionary genetics. Columbia University Press, New York, 1987.
 
15) Roizman B., Tognon M. : Restiction endonuclease patterns of herpes simplex virus ; application to diagnosis and molecular epidemiology. Curr. Topics Microbiol. Immunol., 104 : 279-286, 1983.
 
16) Saito H., Sakaoka H., Yamashita T., et al. : A tandem repeat sequence found in a heterogeneous fragment of ULI of herpes simplex virus type 1. J. Gen. Virol., 70 : 443-448, 1989.
 
17) Sakaoka H., Aomori T., Ozaki I., et al. : Restriction endonuclease cleavage analysis of herpes simplex virus isolates obtained from three pairs of siblings. Infect. Immunit., 43 : 771-774, 1984.
 
18) Sakaoka H., Aomori T., Honda O., et al. : Subtypes of herpes simplex virus type 1 in Japan : classification by restriction endonucleases and analysis of distribution. J. Infect. Dis., 153 : 190-197, 1985.
 
19) Sakaoka H., Saheki Y., Uzuki K., et al. : Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns. J. Clin. Microbiol., 24 : 36-40, 1986.
PubMed
20) Sakaoka H., Saito H., Sekine K., et al. : Genomic comparison of herpes simplex virus type 1 isolates from Japan, Sweden and Kenya. J. Gen. Virol, 68 : 749-764, 1987.
 
21) Sakaoka H., Kurita K., Iida Y., et al. : Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries : studies of molecular evolution and molecular epidemiology of the virus. J. Gen. Virol., 75 : 513-527, 1994.
PubMed
22) Sakaoka H., Kurita K., Gouro T., et al. : Analysis of genomic polymorphism among herpes simplex virus type 2 isolates from four areas of Japan and three other countries. J. Med. Virol., 45 : 259-272, 1995.
PubMed
23) Sakaoka H., Aomori T., Gouro T., et al. : Demonstration of either endogenous recurrence orexogenous reinfection by restriction endonuclease cleavage analysis of herpes simplex virus from patients with recrudescent genital herpes. J. Med. Virol, 46 : 387-396, 1995.
PubMed
24) Umene K., Sakaoka H. : Homegeneity and diversity of genome polymorphism in a set of herpes simplex virus type 1 strains classified as the same genotypic group. Arch. Virol, 119 : 53-65, 1991.
 
P.150 掲載の参考文献
1) Nahmias A., Dowdle W. : Antigenic and biologic differences in hepesvirus hominis. Prog. Med. Virol., 10 : 110, 1968.
 
2) Nicholson K.G. : Antiviral therapy. Lancet, 2 : 736-738, 1984.
PubMed
3) Hanshaw J.B. : Herpes simplex virus infection of the fetus and newborn. In : Viral diseases of the fetus and newborn. 2nd ed.(ed. by Hanshaw J.B.), WB Saunders, Philadelphia, 1985, pp. 132-153.
 
4) 渡辺徹 : 単純疱疹ウイルス胎内感染の1例. 新生児誌, 21 : 780-784, 1985.
 
5) Whitley R.J. : Herpes simplex viruses. In : Fields virology. 3rd ed. (ed. by Field B.N. et al), Lippincott-Raven, Philadelphia, 1996, pp. 2297-2342.
 
6) Boucher F.D., Yasukawa L.L., Bronzan R.N., et al. : A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy. Pediatr. Infect. Dis. J., 9 : 499-504, 1990.
PubMed
7) 森島恒雄 : 先天性ウイルス感染症 : 単純ヘルペスウイルス. 臨床と微生物, 18 : 173-176, 1991.
 
8) 川名林治, 佐藤成大, 金生英雄 : 新生児単純ヘルペスの水平感染. 周産期医学, 13 : 1369-1373, 1983.
 
9) Sakaoka H., Uzuki K., Nakakita K., et al. : Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns. J. Clin. Microbiol, 24 : 36-40, 1986.
 
10) Sullivan-Bolyai J.Z., Fife K.H., Jacobs R.F., et al. : Disseminated neonatal herpes simplex virus type 1 from a maternal breast lesion. Pediatrics, 71 : 455-457, 1983.
PubMed
11) Committee on fetus and newborn, Committee on infectious disease. Perinatal herpes simplex virus. Pediatrics, 66 : 147-149, 1980.
 
12) 森島恒雄, 川名尚, 平山宗宏 : 新生児ヘルペス全国調査, 日児誌, 93 : 1990-1995, 1989.
 
13) 森島恒雄, 川名尚, 厚生省母子感染防止に関する研究班 : 新生児単純ヘルペスウイルス感染症全国調査(第2回)第43回日本ウイルス学会総会抄録集, 1995, p 90.
 
14) Whitley R.J., Corey L., Arvin A., et al. : Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis., 158 : 109-116, 1988.
PubMed
15) Kuzushima K., Kimura H., Kino Y., et al : Clinical manifestation of primary herpes simplex virus type 1 infection in a closed community. Pediatrics, 87 : 152-158, 1991.
 
16) Argyris B.F. : The interaction between macrophages and suppressor cells in immunological maturation in mice. Immunology Today, 5 : 34-36, 1984.
PubMed
17) Kohl S. : Defective infant antiviral cytotoxicity to herpes simplex virus infected cells. J. Pediatr., 102 : 885-888, 1983.
 
18) Whitley R.J., Arvin A.M. : Herpes simplex virus infection. In : Infectious diseases of the fetus and newborn infant (ed. by Remington J.S., et al.), WB Saunders, Philadelphia, 1995, pp. 354-376.
 
19) 森島恒雄. 単純ヘルペスの母子感染. 小児医学, 24.669-681, 1991
 
20) Kimura H., Futamura M., Kito H., et al. : Detection of viral DNA in neonatal herpes simplex virus infections : Frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis., 164 : 289-293, 1991.
PubMed
21) Morishima T. : New diagnostic techniques for the management of herpesviruses. Herpes, 3 : 5-13, 1996.
 
22) 倉田毅, 佐多徹太郎, 山本あつ子, 他 : 新生児および成人の全身感染. ウイルス感染症の臨床と病理 (青山友三, 他 編), 医学書院, 1991, pp. 39-42.
 
23) 森島恒雄 : ヘルペス感染症の治療. 最新医学, 44 : 94-98, 1989.
 
24) Whitley R.J., Nahmias A.J., Soong S.J., et al. : Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics, 66 : 495-501, 1980.
PubMed
25) Whitley R., Arvin A., Prober C., et al. : A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection, N. Engl. J. Med., 324 : 444-449, 1981.
 
26) 川名尚 : 単純ヘルペスウイルスの母子感染. 周産期医学, 13 : 1361-1367, 1983.
 
27) Whitely R., Arvin A., Prober C., et al. : Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N. Engl. J. Med., 324 : 450-454.1991.
 
28) 木村宏, 葛島清隆, 森島恒雄, 他 : 新生児ヘルペス全身型に伴う肝機能異常の早期診断における重要性について. 日児誌, 95 : 955-959, 1991.
 
P.156 掲載の参考文献
1) Klapper P. E., Laing I., Longston M. : Rapid non-invasive diagnosis of herpes encephalitis. Lancet, 2 : 607-609, 1981.
 
2) Rowley A. H., Whitley R. J., Lakeman F. D., Wolinsky S.M. : Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet, 335 : 440-441, 1990.
PubMed
3) Kimura H., Futamura M., Kito H., Ando T., Goto M., Kazushima K., Shibata M., Morishima T. : Detection of viral DNA in neonatal herpes simplex virus infections : frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis., 164 : 289-293, 1991.
 
4) Shoji H., Koga M., Kusuhara T., Kaji M., Ayabe M., Hino H., Hondo R. : Differentiation of herpes simplex virus 1 and 2 in cerebrospinal fluid of patients with HSV encephalitis and meningitis by stringent hybridization of PCR-amplified DNAs. J. Neurol., 241 : 526-530, 1994.
PubMed
5) Kamei S., Tetsuka T., Takasu T., Shimizu K. : New non-invasive rapid diagnosis of herpes simplex virus encephalitis by quantitative detection of intrathecal antigen with a chemiluminescence assay. J.Neurol. Neurosurg. Psychiatry, 57 : 1112-1114, 1994.
PubMed
6) Kostiniemi M., Piiparinen H., Mannonen L, Rantalaiho T., Vaheri A. : Herpes encephaltitis is a disease of middle aged and elderly people : polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. J. Neurol. Neurosurg. Psychiatry, 60 : 174-178, 1996.
 
7) Inouye S., Hondo R. : Type differentiation of herpes simplex virus by stringent hybridization of polymerase chain reaction product. Arch. Virol., 129 : 311-316, 1993.
PubMed
8) Rozenberg F., Lebon P. : Amplification and characterization of herpesvirus DNA in cerebrospinal fluid from patients with acute encephalitis. J. Clin. Microbiol., 29 : 2412-2417, 1991.
PubMed
9) Schroth G., Gawehn J., Thron A., Vallbracht A., Voigt K. : Early diagnosis of herpes sirnplex encephalitis by MRI. Neurology, 37 : 179-183, 1987.
PubMed
10) Nakajima H., Furutama D., Kimura F, Shinoda K., Nakagawa T., Shimizu A., Ohsawa N. : Herpes simplex virus type 2 infections presenting as brainstem encephalitis and recurrent myelitis. Internal Medicine, 34 : 839-842, 1995.
PubMed
P.163 掲載の参考文献
1) 本田まりこ, 横井清, 新村眞人 : FITC標識抗HSV, 抗VZV抗体による臨床材料の検討. 臨床とウイルス, 18 : 35-40, 1990.
Medical*Online
2) 川名尚, 倉田毅, 川名林治, 新村眞人, 森良一 : 蛍光標識モノクローナル抗体(Micro Trac Herpes)による単純ヘルペスウイルス感染症の診断. 感染症誌, 61 : 1030-1037, 1987.
 
3) 川名尚, 橋戸円, 菅生元康, 坂岡博, 倉田毅, 鈴木理恵子 : 抗単純ヘルペスウイルスモノクローナル抗体により検出できない臨床分離株の出現頻度. 臨床とウイルス, 19 : 376-380, 1991.
 
4) 本田まりこ, 新村眞人 : ヘルペスウイルス・臨床-性器ヘルペスの検査法の適用の仕方とその読み方-. 日本性感染症誌, 2 : 58-62, 1991.
 
5) 山口優樹, 荒尾雄二郎, 倉田毅, 他 : DNA診断による単純ヘルペスウイルスの型判定. 臨床とウイルス, 24 : 63-68, 1996.
Medical*Online
6) Cockkroft D.W., Gault M.H. : Prediction of creatinine clearance from serum creatinine. Nephron, 31-41, 1976.
 
P.168 掲載の参考文献
1) 安元慎一郎 : 単純ヘルペスウイルスに対する表皮を介した免疫応答とその抑制. 医学のあゆみ, 155 : 661, 1990.
Medical*Online
2) 小野公義 : 性器ヘルペスの統計. 皮膚病診療, 17 : 1206-1207, 1995.
 
3) 林嘉信, 安元慎一郎, 森良一, 安田勝, 水田良子, 柿原由美子 : 女性陰部疱疹の臨床ウイルス学的研究. 西日皮膚, 46 : 363-347, 1984.
 
4) Gold D., Ashley R., Solberg G., Abbo H., Corey L. : Chronic-dose Acyclovir to suppress frequently recurring genital herpes simplex virus infection : Effect on antibody response to herpes simplex virus type 2 proteins. J. Infect. Dis., 158 : 1227-1234, 1988.
PubMed
5) Mertz G. J., Ashley R., Burke RL, Beneditti J., Critchlow C., Jones C.C., Corey L. : Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J. Infect. Dis., 161 : 653-660, 1990.
 
P.175 掲載の参考文献
1) Kawana T., Kawaguchi T., Sakamoto S. : Clinical and virological studies on genital herpes. Lancet, 2 : 964, 1976.
PubMed
2) Lafferty W. E, Coombs RW., Benedetti J., et al. : Recurrences after oral and genital HSV infection. N. Engl. J. Med., 316 : 1444-1449, 1987.
PubMed
3) 川名尚 : 性器Herpes. 臨床と微生物, 22 : 278-285, 1995.
Medical*Online
4) 川名尚, 橋戸円 : 急性性器ヘルペスに対する経口Acyclovir錠の効果. 感染症誌, 62 : 313-321, 1988.
 
5) 川名尚 : 性器ヘルペスに対する5%アシクロビル. 軟膏の効果. Chemotherapy, 40 : 1460-1471, 1992.
 
6) Centers for Disease Control and Prevention, 1993, Sexually transmitted diseases treatment guidelines. MMWR, 42 No. RR-14, 1993.
 
7) Fife K. H., Crumpacker C. S., Mertz G. J., et al. : Recurrence and resistance patterns of herpes simplex virus following cessation of≧6 years of chronic suppression with Acyclovir. J. Infect. Dis., 169 : 1338-1341, 1994.
 
P.180 掲載の参考文献
1) Douville P., Hagmann M., Georgiev O., et al. : Positive and negative regulation at the herpes simplex virus ICP4 and ICPO TAATGARAT motifs. Virology, 207 : 107-116, 1995.
 
2) Nesburn A. B., Dickinson R, Radnoti M. : The effect to trigeminal nerve and ganglion manipulation on recurrence of ocular herpes simplex in rabbits. Invest. Ophthalmol., 15 : 726-731, 1976.
PubMed
3) 下村嘉一 : 角膜ヘルペスと再発. 眼科, 32 : 47-52, 1990.
 
4) Nishida T., Ohashi Y., Awata T., et al. : Fibronectin ; A new therapy for corneal trophic ulcer. Arch. Ophthalmol., 101 : 1046-1048, 1983.
PubMed
5) Shimomura Y., Ohashi Y., Maeda N, et al. : Herpetic keratitis therapy to reduce recurrence. Curr. Eye Res., 6 : 105-110, 1987
PubMed
6) Easty D. L., Shimeld C., Claoue C.MP., et al. : Herpes simplex virus isolation in chronic stromal keratitis : Human and laboratory studies. Curr. Eye Res., 6 : 69-74, 1987.
 
7) Shimomura Y., Mori Y., Inoue Y., et al. : Herpes simplex virus latency in human cornea. Jpn. J. Ophthalmol., 37 : 318-324, 1993
PubMed
8) Mitchell W. J., Gressens P., Martin J. R., et al. : Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J. Gen. Virol., 75 : 1201-1210, 1994.
PubMed
P.186 掲載の参考文献
1) Meyers J.D., Flournoy N, Thomas E.D. : Infection with herpes simplex virus and cell-mediated immunity after marrow transplantation. J. Infect. Dis., 142 : 338-346, 1980.
PubMed
2) Johnson J.R., Egaas S., Gleaves C.A., Hackman R, Bowden R.A : Hepatitis due to herpes simplex virus in marrow transplant recipients. Clin. Infect. Dis., 14 : 38-45, 1992.
PubMed
3) Ramsay P.G., File K.H., Hackman R.C., Meyers J.D., Corey L. : Herpes simplex virus pneumonia. Ann. Intern. Med., 97 : 813-820, 1982.
 
4) Whitley R.J., Alford C.A., Hirsch M.S., Schooley R.T., Luby J.P., Aoki F.Y., Hanley D., Nahmias A.J., Soong SJ. : Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J.Med., 314 : 144-149, 1986.
PubMed
5) Mitchell C.D., Bean B., Gentry S.R., Groth K.E., Boen J.R., Balfour H.H. : Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet, 8235 : 1389-1392, 1981.
PubMed
6) Saral R, Burns W.H., Laskin O.L., Santos G.W., Lietman P.S. : Acyclovir prophylaxis of herpes-simplex-virus infection. N. Engl. J. Med., 305 : 63-67, 1981.
PubMed
7) Safrin S., Crumpacker C., Chatis P. : A controlled trial comparing foscarnet with vidarabine for acyclovir-resistent mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trial Group. N. Engl. J. Med., 325 : 551-555, 1991
 

III. 水痘・帯状疱疹の臨床

P.198 掲載の参考文献
1) 永井崇雄, 浅野喜造, 板倉尚子, 岡藤輝夫, 尾崎隆男, 落合仁, 勝島矩子, 梶田祐司, 喜多村哲朗, 島田康, 須賀定雄, 竹広晃, 徳丸実, 永井幸夫, 宮田隆夫, 吉川哲史 : 健康小児の自然水痘重症度に関する臨床的検討-I. 1才以上の年長児例を中心に-. 小児科臨床, 投稿中
 
2) Baba K., Yabuuchi H., Takahashi M., Ogra P. L. : Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy : Community-based follow-up study. J.Pediatr., 108 : 372-377, 1986.
PubMed
3) Grose C. : Variation on a theme by Fenner : The Pathogenesis of chickenpox. Pediatrics, 68 : 735-737, 1981.
PubMed
4) Asano Y., Itakura N., Hiroishi Y., Hirose S., Ozaki T., Kuno K., Nagai T., Yazaki T., Yamanishi K., Takahashi M. : Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J. Infect. Dis., 152 : 863-868, 1985.
PubMed
5) Ozaki T., Kajita Y., Asano Y., Aono T., Yamanishi K. : Detection of varicella-zoster virus DNA in blood of children with varicella. J. Med. Virol., 44 : 263-265, 1994.
PubMed
6) Ozaki T., Masuda S., Asano Y., Kondo K., Namazue J., Yamanishi K. : Investigation of varicellazoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination. J.Med. Virol., 42 : 47-51, 1994.
PubMed
7) 永井崇雄, 浅野喜造, 板倉尚子, 岡藤輝夫, 尾崎隆男, 落合仁, 勝島矩子, 梶田祐司, 喜多村哲朗, 島田康, 須賀定雄, 竹広晃, 徳丸実, 永井幸夫, 宮田隆夫, 吉川哲史 : 健康小児の自然水痘重症度に関する臨床的検討-II. 乳児例について-. 小児科臨床, 投稿中
 
8) 永井崇雄, 勝島矩子, 山中樹, 鎌田誠 : 健康小児の水痘再罹患例について. 小児感染免疫, 8 : 75, 1996.
 
9) Gershon A. A. : Varicella-Zoster Virus : Prospects for control. In : Advances in Pediatric Infectious Diseases. vol. 10, Mosby-Year Book Inc., St. Louis, 1995, pp. 93-124.
 
10) Newman C.G.H. : Perinatal Varicella. Lancet, Dec. 4 : 1159-1161, 1965.
 
11) Gershon A. A., Steinberg S. P., Gelb L., The National Institute of Allergy and Infectious Diseases Collaborative Varicella Vaccine Study Group : Clinical reinfection with varicella-zoster virus. J.Infect. Dis., 149 : 137-142, 1984.
 
12) 永井崇雄 : 水痘ワクチン接種後遠隔罹患例と自然水痘再罹患例における水痘特異免疫の検討. 予防接種の効果と副反応の追跡調査及び予防接種の社会・経済効果に関する研究. 厚生省予防接種副反応研究班総会資料, 予防接種リサーチセンター, 1996, pp. 117-120.
 
13) Asano Y., Yoshikawa T., Suga S., Kobayashi I., Nakashima T., Yazaki T., Ozaki T., Yamada A., Imanishi J. : Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics, 92 : 219-222, 1993.
PubMed
P.203 掲載の参考文献
1) 本藤良 : 水痘・帯状疱疹の血清疫学. ヘルペスの診療Q&A(新村眞人編), 臨床医薬研究協会, 1993, pp. 180-181.
 
2) Krugman S., Katz S.L. : Varicella-zoster infections. In : Infections Diseases of Children. Mosby, 1981, pp. 486-506.
 
3) 神谷齊 : 水痘の合併症. 水痘・帯状疱疹(高橋理明, 新村眞人編), メディカルトリビューン, 1987, pp. 116-123.
 
4) 喜多村勇 : 水痘.臨床とウイルス, 13 : 23-30, 1985.
Medical*Online
P.212 掲載の参考文献
1) 小野公義 : サーベイランスからみた帯状疱疹の統計. 西日皮膚, 56 : 763-767, 1994.
 
2) Roizmann B., Desrosiers R.C., Fleckenstein B., et al. : The family Herpesviridae. Arch. Virol., 123 : 425-449, 1992.
PubMed
3) 漆畑修 : 帯状疱疹の臨床と診断. 薬局, 45 : 1857-1863, 1994.
 
4) 漆畑修 : 帯状疱疹. 皮膚疾患, 最新の治療 '93-'94(西山茂夫, 島雄周平, 堀嘉昭編), 南江堂, 東京, 1993, pp. 160-162.
 
5) 漆畑修 : 帯状疱疹. 医療ジャーナル, 29 : 2637-2641, 1993.
 
6) Gilden D.H., Dueland A.N, Cohrs R, et al. : Preherpetic neuralgia. Neurology, 41 : 1215-1218, 1991.
PubMed
7) Gilden D.H., Dueland A.N, Devlin M.E, et al. : Varicella-zoster virus reactivation without rash. J.Infect. Dis., 166 (Suppl.1) : 30-34, 1992.
 
8) 漆畑修 : 運動麻痺を伴う帯状疱疹. 医学のあゆみ, 151 : 348, 1989.
Medical*Online
9) Hunt J.R. : On herpettic inflammation of the geniculate ganglion. J. Nerv. Ment. Dis., 34 : 73-96, 1907.
 
10) Rusthoven J.J., Ahlgren P., Elhakim T., et al. : Varicella-zoster infection in adult cancer patients. Arch. Intern. Med., 148 : 1561-15656, 1988.
PubMed
11) Hoppenjans W.B., Bibler M.R, Orme R.L, et al. : Prolonged cutaneous herpes zoster in aquired immunodeficiency syndrome. Arch. Dermatol., 126 : 1048-1050, 1990.
 
12) 宮崎東洋 : 帯状疱疹後神経痛とは. ヘルペスの治療Q&A. 新村眞人編, 臨床医薬研究協会, 東京, 1993, pp. 196-197.
 
13) 新村眞人, 倉田毅, 坂岡博, 他 : 蛍光標識モノクロナール抗体による水痘・帯状疱疹ウイルス感染症の診断. 感染症誌, 64 : 195-201, 1990.
 
14) 川名誠司, 沈国雄, 中村健一 : 帯状疱疹に伴う疼痛に対する抗うつ薬(レスリン錠)の使用経験. 西日皮膚, 57 : 150-153, 1995.
 
15) 漆畑修 : 帯状疱疹のステロイド内服療法. 臨皮, 49(5増) : 164-165, 1995.
 
16) 漆畑修 : 帯状疱疹に対するグリチルリチンの作用. 西日皮膚, 50 : 494-498, 1998.
 
P.218 掲載の参考文献
1) Korner O. : Uber den Herpes zoster oticus. Munch. Med. Wschr., 51 : 6-7, 1904.
 
2) Hunt J.R. : On herpetic inflammations of the geniculate ganglion, a new syndrome and its complication. J. Nerv. Ment. Dis., 34 : 73-96, 1907.
 
3) 小池吉郎, 市毛明彦, 青柳優, 他 : 発生状況に関する全国統計の分析.「特発性顔面神経麻痺に関する疫学・臨床的研究」研究成果報告書, 1987, pp. 4-9.
 
4) 阿部隆 : Bell麻痺およびRamsay Hunt症候群の統計的観察-臨床像の検討と鑑別診断について-. 日耳鼻, 84 : 608-617, 1981.
 
5) Hunt J.R. : Geniculate neuralgia (neuralgea of the nervus facialis). A further contribution to the sensory system of the facial nerve and its neuralgic conditions. Arch. Neurol. Psychiat., 37 : 253-285, 1937.
 
6) 池田稔, 久元延生, 大森英生, 他 : Ramsay Hunt症候群に伴う口腔咽頭ヘルペス. 耳鼻咽喉科・頭頸部外科, 61 : 248-249, 1989.
 
7) 塩谷正弘, 若杉文吉, 湯田康正, 他 : 帯状疱疹に合併する運動麻痺. ペインクリニック, 1 : 119-127, 1980.
 
8) 蓑和田寛子 : 顔面神経麻痺の臨床的研究. 耳鼻臨床, 62 : 735-798, 1969.
 
9) 冨田寛, 池田稔 : Bell麻痺とHunt症候群の関係. 顔面神経障害-基礎と臨床-(冨田寛, 監修). 現代医療社, 東京, 1984, pp. 239-244.
 
10) Stennert E. : New concepts in the treatment of Bell's palsy. In : Disorder of the Facial Nerve (ed. by Graham M.D., House W.F.). Raven Press, New York, 1982, pp. 313-318.
 
P.224 掲載の参考文献
1) 北野周作, 笠松容子 : 帯状疱疹と眼合併症. 水痘・帯状疱疹(高橋理明, 新村眞人編). メディカルトリビューン, 1987, pp. 102-109.
 
2) 内田幸男 : 眼部帯状ヘルペス(herpes zoster ophthalmicus). 眼とヘルペス(眞鍋禮三編). 医学書院, 1990, pp. 46-51.
 
3) Piebenga L.W., Laibson P.R. : Dendritic lesions in herpes zoster ophthalmicus. Arch. Ophthalmol., 90 : 268-270, 1973.
PubMed
4) 内田幸男, 亀山和子, 金子行子, 井上福子, 養田芳子, 半田幸子 : 帯状ヘルペス角膜炎の病像について. 日眼会誌, 78 : 1073-1078, 1974.
 
5) 内藤毅, 新田敬子, 木内康仁, 塩田洋, 三村康男 : 当教室における眼部帯状ヘルペスについて. あたらしい眼科, 7 : 1359-1361, 1990.
 
6) Marsh R.J., Easty D.L, Jones B.R. : Iritis and iris atrophy in herpes zoster ophthalmicus. Am. J.Ophthalmol., 78 : 255-261, 1974.
PubMed
7) 原二郎 : 帯状ヘルペスその他のウイルス性眼疾患. 眼科Mook No.7 眼感染症とその治療(三島済一, 塚原勇, 植村恭夫, 内田幸男編). 金原出版, 1979, pp. 66-77.
 
P.230 掲載の参考文献
1) Suer G.C. : Herpes zoster : treatment of postherpetic neuralgia with cortisone, corticutropin, and placebos. Arch. Dermatol., 71 : 488-491, 1955.
 
2) Riopelle J.M., Naraghi M., Grush K.P. : Chronic neuralgia incidence following local anesthetic therapy for herpes zoster. Arch. Dermatol., 120 : 747-750, 1984.
PubMed
3) Colding A. : Effect of regional sympathetic blocks in the treatment of herpes zoster. Acta. Anaesth. Scand., 13 : 133-141, 1969.
 
4) 宮崎東洋 : ニューロパシックペイン. ペインクリニック, 17 : 45-52, 1996.
 
5) Hope-Shimpson R.E. : The nature of herpes zoster : a long term study and a new hypothesis. Proc. R.Soc. Med., 58 : 9-20, 1965.
 
6) Gelb L.D. : Varicella zoster virus. Virology (ed. by Field B.N.), Raven Press, 1985, pp. 2011-2054.
 
7) Melzack R., Wall P.D. : Pain mechanisms, A new theory. Science, 150 : 971-979, 1965.
PubMed
8) Robert W.J. : The hypothesis on the physiological basis for causalgia and related pain. Pain, 24 : 297-311, 1986.
 
9) Dan K. : Nerve block therapy and postherpetic neuralgia. Critical Reviews in Physical and Rehabilitation. Medicine, 7 : 93-112, 1995.
 
P.239 掲載の参考文献
1) Takahashi M., Otsuka T., Okuno Y., et al. : Live vaccine used to prevent the spread of varicella in children in hospital. Lancet, 2 : 1288-1290, 1974.
PubMed
2) WHO Expert committee on Biological standarization. Riquirements for varicella vaccine (live) (Requirements for Biological Substances No.36) WHO, Geneva, 1985, pp. 102-133.
 
3) Gershon A. A. : Varicecella-zoster virus ; Prospects for control. In : Advances in Pediatric Infectious Diseases, vol.10. Mosby-Year Book Inc., 1995, pp. 93-124.
 
4) Hall C. B. : The use of oral acyclovir in otherwise healthy children with varicella. Pediatrics, 91 : 674, 1993.
 
5) Hayakawa Y., Torigoe S., Shiraki K., et al. : Biological and biophysical markers of a live varicellavaccine (Oka strain) ; indentification of a clnical isolates from vaccine recipients. J. Infect. Dis., 149 : 956-963, 1984.
 
6) Hayakawa Y., Yamamoto T., Yamanishi K., et al. : Analysis of varicella zoster virus(VZV) DNAs of clinical isolates by endonuclease Hpa I. J. Gen. Virol., 67 : 1817-1829, 1986.
 
7) Kinchington P.R., Ling P., Pensiero M., et al. : The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine staim (Oka). J. Virol., 64 : 6540-6548, 1990.
 
8) 神谷齊 : 小児白血病患児への水痘ワクチン接種後の追跡と2～3の問題点について. 臨床とウイルス, 11 : 28-32, 1983.
 
9) Takahashi M., Gershon A. : Varicella vaccine in "Vaccines" second edition. (ed. by Plotkin S.A., Morthmer E.R. Jr.) W.B. Saunders, Philadelphia, 1994, pp. 387-417.
 
10) 神谷齊, 庵原俊昭, 藤原卓, 他 : 20機関, 水痘ワクチン接種全国集計結果(第4報)平成7年3月厚生省予防接種副反応研究班. 予防接種リサーチセンター
 
11) Vesikari T. : Protectire efficacy in healthy children. Abstract p.83, Meeting for the next generation. Sorrento, Italy.
 

IV. その他のヘルペスウイルス感染症の臨床

P.249 掲載の参考文献
1) 正岡徹, 中島章, 南谷幹夫, 他 : サイトメガロウイルス感染症に対する抗ウイルス剤ガンシクロビルの治療成績.臨床とウイルス, 20 : 59-70, 1992.
Medical*Online
2) Grundy J.E., Shanley J.D., Griffiths P.D. : Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet, 2 : 996-999, 1987.
PubMed
3) 立川豊史, 横田貴史, 尾路祐介, 他 : 同種骨髄移植後のサイトメガロウイルス肺炎早期発見のための血中同ウイルス抗原モニタリング, 動脈血中酸素飽和度測定の有効性の検討. 臨床血液, 35 : 1261-1266, 1994.
 
4) Meyers M.D., Flourney N., Thomas E.D., et al. : Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis., 153 : 478-488, 1986.
 
5) Engight H., Haake R., Weisdorf D., et al. : Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplant, 55 : 1339-1346, 1993.
 
6) Paulin T., Ringden O., Lonnqvist B., et al. : The importance of pre-bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors. Scand. J.Infect. Dis., 18 : 199-209, 1986.
PubMed
7) Winston D.J., Huang E.-S., Miller M.J., et al. : Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. Ann. Intern. Med., 102 : 16-20, 1985.
PubMed
8) Bowden RA., Slichter SJ., Sayers M.H., et al. : Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood, 78 : 246-250, 1991.
PubMed
9) Miller W.J., McCullough J., Balfour H.H., et al. : Prevention of cytomegalovirus infection following bone marrow transplantation : A randomized trial of blood product screening. Bone Marrow Transplant, 7 : 227-234, 1991.
PubMed
10) Bowden R.A, Slichter S.J., Sayers M., et al. : A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood, 86 : 3598-3603, 1995.
 
11) 正岡徹, 井上俊彦 : 骨髄移植の適応と成績. 癌と化学療法, 13 : 1811-1815, 1986.
Medical*Online
12) Goodrich J.M, Boeckh M., Bowden R. : Strategies for the prevention of cytomegalovirus disease after marrow transplantation. Clin. Infect. Dis., 19 : 287-298, 1994.
 
13) Goodrich J.M., Bowden R.A., Fisher L., et al. : Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann. Intern. Med., 118 : 173-178, 1993.
PubMed
14) Winston D.J., Ho W.G., Bartoni K., et al. : Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients : results of a placebo-controlled, double-blind trial. Ann. Intern. Med., 118 : 179-184, 1993
PubMed
15) Schmidt G.M., Horak D.A., Niland J.C. et al. : A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N. Engl. J. Med., 324 : 1005-1011, 1991
PubMed
16) Goodrich J.M., Mori M., Gleaves C.A. et al. : Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N. Engl. J. Med., 325 : 1601-1607, 1991.
PubMed
17) Singhal S., Mehta J., Powles R., et al. : Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation. Bone Marrow Transplant, 15 : 777-781, 1995.
PubMed
18) Li C.-R., Greeberg P.D., Gilbert M.J. et al. : Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant : Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood, 83 : 1971-1979, 1994.
 
19) Razis E, Cook P., Mittelman A., et al. : Treatment of ganciclovir resistant cytomegalovirus with foscarnet : a report of two cases occurring after bone marrow transplantation. Leukemia and Lymphoma, 12 : 477-480, 1994.
PubMed
20) Bacigalupo A., van Lint M.T., Tedone E. et al. : Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir. Bone Marrow Transplant., 13 : 753-758, 1994.
 
21) Aschau J., Ringden O., Ljungman P., et al. : Foscarnet for treatment of cytomegalovirus infections in marrow transplant recipients. Scand. J. Infect. Dis., 24 : 143-150, 1992.
 
22) 菅野徹, 松本洋一, 北原滋久他 : 抗ヒトサイトメガロウイルスモノクローナル抗体製剤, TI-23による細胞間感染抑制. 今日の移植, 7 : 289-292, 1994.
 
23) 正岡徹, 新津洋司郎, 浅野茂隆他 : 骨髄移植後のサイトメガロウイルス感染症に対する抗サイトメガロウイルスヒトモノクローナル抗体, C23製剤(TI-23)の臨床評価. 今日の移植, 7 : 395-403, 1994.
Medical*Online
24) Einsele H., Ehninger G., Hebart H., et al. : Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood, 86 : 2815-2820, 1995.
PubMed
25) 正岡徹, 平岡帝, 浅野茂隆他 : HRP-C7を用いた骨髄移植後のサイトメガロウイルス感染症の早期診断とモニタリング. 今日の移植, 7 : 543-551. 1994.
 
26) Przepiorka D., Ippoliti C., Panina J., et al. : Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplant., 13 : 461-464, 1994.
 
P.257 掲載の参考文献
1) 脇口宏, 藤枝幹也, 松本健治, 他 : 乳幼児の急性EBウイルス感染症の臨床免疫学的研究. 3. EBウイルス特異的キラーT細胞活性と白血球数の年齢, 病型による比較. 日児誌, 91 : 2843-2848, 1987.
 
2) 脇口宏, 久保田晴郎, 久川浩章, 他 : 伝染性単核症におけるリンパ球サブセットの分析. 日児誌, 95 : 2228-2232, 1991.
 
3) Miyawaki T., Kasahara Y., Kanegane H., et al. : Expression of CD45RO(UCHL1) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis. Clin. Exp. Immunol., 83 : 447-451, 1991.
PubMed
4) Schooley R. T., Densen P., Harmon D., et al. : Antineutrophil antibodies in infectious mononucleosis. Am. J. Med., 76 : 85, 1984.
PubMed
5) 脇口宏, 藤枝幹也, 松本健治, 他 : 乳幼児の急性Epstein-Barr(EB)ウイルス感染症の臨床免疫学的研究. 1. 肝機能障害の病日的推移と年齢, 病型による比較. 小児科臨床, 40 : 3001-3005, 1987.
 
6) 石原重彦, 河敬世, 岡田伸太郎, 他 : 本邦における慢性活動性EBウイルス感染症の特徴. 1. 臨床像および疫学的検討.日児誌, 95 : 80-90, 1991.
 
7) 脇口宏, 藤枝幹也, 松本健治, 他 : 乳幼児の急性 Epstein-Barr(EB) ウイルス感染症の臨床免疫学的研究. 2. EBウイルス抗体の年齢, 病型による比較. 臨床とウイルス, 15 : 247-253, 1987.
Medical*Online
8) Sumaya C.V., Ench Y. : Epstein-Barr virus infectious mononucleosis in children. II. Heterophile antibody and viral specific responses. Pediatr., 75 : 1011-1019, 1985.
 
9) Sumaya C.V., Ench Y. : Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general laboratory findings. Pediatr., 75 : 1003-1010, 1985.
 
10) 久川浩章, 脇口宏, 久保田晴郎, 他 : 小児伝染性単核症におけるリンパ球サブセットの年齢による分析. 小児感染免疫, 7 : 213-217, 1995.
 
11) Uehara T., Miyawaki T., Ohta K., et al. : Apoptotic cell death of primed CD45RO+T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood, 80 : 452-458, 1992.
PubMed
12) Akbar A.N., Borthwick N, Salmon M., et al. : The significance of low bcl-2 expression by CD45RO+T cells in norrnal individuals and patients with acute viral infections. The role of apoptosis in T cell momory. J. Exp. Med., 178 : 427-438, 1993.
 
13) Moore K.W., O'Garra A., de Waal, et al. : Interleukin-10. Ann. Rev. Immunol., 11 : 165-190, 1993.
 
14) Taga H., Taga K., Wang F., et al. : Human and viral interleukin-10 in acute Epstein-Barr virus-induced infectious mononucleosis. J. Infect. Dis., 171 : 1347-1350, 1995.
PubMed
15) Stewart J. P., Rooney C. M. : The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of cytotoxic T cell and HLA-unrestricted killer responses. Virol., 191 : 773, 1992.
 
16) Gan Y.-J., Sullivan J. L., Sixbey J. W. : Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J. Infect. Dis., 170 : 436-439, 1994.
PubMed
17) Andersson J., Britton S., Ernberg I., et al. : Effect of acyclovir on infectious mononucleosis : adouble blind, placebo-controlled study. J. Infect. Dis., 153 : 283-290, 1986.
 
18) 河敬世, 土井悟, エリア・フランコ, 他 : 慢性活動性EBV感染症にみられる活性化T細胞-rIL-2の臨床応用-. 医学のあゆみ, 139 : 1037-1038, 1986.
 
19) 脇口宏, 藤枝幹也, 武知知己, 他 : 慢性活動性EBウイルス感染症児のIL-2による治療と免疫能の変化. 臨床とウイルス, 19 : 365-370, 1992.
 
20) Schooley RT., Carey R.N., Miller G., et al. : Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serological features and response to antiviral chemotherapy. Ann. Intern. Med., 104 : 636-643, 1986.
 
21) Kawaguchi H., Miyashita T., Herbst H., et al. : Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J. Clin. Invest., 92 : 1444-1450, 1993.
PubMed
22) Ohshima K., Kikuchi M., Mizuno S., et al : Hepatosinusoidal leukemia/lymphoma consisting of Epstein-Barr virus-containing natural killer cell leukemia/lymphoma and T-cell lymphoma : mimicking malignant histiocytosis. Hematol. Oncol., 13 : 83-97, 1995.
 
23) 今宿晋作 : 血球貧食症候群(Hemophagocytic syndrome, HPS). 日小血会誌, 5 : 349-360, 1991.
 
P.263 掲載の参考文献
1) Pallesen G., Hamilton-Dutoit S. J., Zhou X. : The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease : two new developments in the EBV field. Adv. Cancer Res., 62 : 179-239, 1993.
 
2) Rowe M., Gregory C. : Epstein-Barr virus and Burkitt's lymphoma. Adv. Viral Oncol., 8 : 237-260, 1989.
 
3) Okano M., Kikuta H., Abo W., et al. : Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma. Jpn. J. Clin. Oncol., 22 : 320-324, 1992.
PubMed
4) Bhatia K., Huppi K., Spangler G., et al. : Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nature Genetics, 5 : 56-61, 1993.
 
5) Shimizu N., Tanabe-Tochikura A., Kuroiwa Y., et al. : Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata : malignant phenotypes of BL cells are dependent on EBV. J. Virol., 68 : 6069-6073, 1994.
PubMed
6) Masucci M. G., Zhang Q.-J., Gavioli R., et al. : Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma : in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Int. Immunol., 4 : 1283-1292, 1992.
PubMed
7) Purtilo D. T., Tatsumi E., Manolov G., et al. : Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. In : Int. Rev. Exp. Pathol. (ed. by Richter G. W., Epstein M.A.), Academic Press Inc., Orland, Fla, 1985, pp. 113-183.
 
8) Starzl T. E., Porter K. A., Iwatsuki S., et al. : Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1 : 583-587, 1984.
PubMed
9) Grierson H., Purtilo D.T. : Epstein-Barr virus infections in males with X-linked lympho-proliferative syndrome. Ann. Intern. Med., 107 : 538-545, 1987.
 
10) MacMahon E. M. E., Glass J.D., Hayward S. D., et al. : Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet, 338 : 969-973, 1991.
 
11) Ziegler J. L., Drew W. L., Miner R. C., et al. : Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet, 2 : 631-633, 1982.
 
12) Young L., Alfieri C., Hennessy K., et al. : Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med., 321 : 1080-1085, 1989.
PubMed
13) Oudejans J. J., Jiwa M., van den Brule A. J. C., et al. : Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am. J. Pathol., 147 : 923-933, 1995.
 
14) Rooney C. M., Loftin S. K., Holladay M. S., et al. : Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br. J. Haematol., 89 : 98-103, 1995.
PubMed
15) Straus S. E., Cohen J. I., Tosato G., et al. : NIH conference. Epstein-Barr virus infections : biology, pathogenesis, and management. Ann. Intern. Med., 118 : 45-58, 1993.
PubMed
16) Sullivan J. L., Medveczky P., Forman S. J., et al. : Epstein-Barr virus-induced lymphoproliferation. Implications for antiviral chemotherapy. N. Engl. J. Med., 311 : 1163-1167, 1984.
PubMed
17) Fischer A., Blanche S., Le Bidois J., et al. : Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N. Engl. J. Med., 324 : 1451-1456, 1991.
 
18) Shapiro R. S., Chauvenet A., McGuire W., et al. : Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N. Engl. J. Med., 318 : 1334, 1988.
PubMed
19) Pracher E., Grumayer-Panzer E. R., Zoubek A., et al. : Bone marrow transplantation during fulminant EBV infection in Duncan's syndrome. Lancet, 342 : 1362, 1993.
 
20) Rooney C. M., Smith C. A., Ng C. Y. C., et al. : Use of gene-modified virus-specific T lymphocytes to control Epstein-Barrvirus-related lymphoproliferation. Lancet, 345 : 9-13, 1995.
 
21) Kuzushima K., Yamamoto M., Kimura H., et al. : Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin. Exp. Immunol., 103 : 192-198, 1996.
PubMed
22) Sasajima Y., Yamabe H., Kobashi Y., et al. : High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am. J. Pathol., 143 : 1280-1285, 1993.
PubMed
23) Ohsawa M., Tomita Y., Kanno H., et al. : Role of Epstein-Barr virus in pleural lymphomagenesis. Modern Pathol., 8 : 848-853, 1995.
 
24) Cesarman E., Chang Y., Moore P. S., et al. : Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med., 332 : 1186-1191, 1995.
PubMed
25) Kon S., Sato T., Onodera K., et al. : Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma. Path. Res. Pract., 189 : 1137-1144, 1993.
 
26) Tokunaga M., Imai S., Uemura Y., et al. : Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am. J. Pathol., 143 : 1263-1269, 1993.
PubMed
27) Weiss L. M., Jaffe E. S., Liu X.-F., et al. : Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood, 79 : 1789-1795, 1992.
PubMed
28) Anagnostopoulos I., Hummel M., Finn T., et al. : Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood, 80 : 1804-1812, 1992.
PubMed
29) Su I.-J., Hsu Y.-H., Lin M.-T., et al. : Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer, 72 : 2019-2027, 1993.
PubMed
30) Yao M., Cheng A. L, Su I.-J., et al. : Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphomas. Br. J. Haematol., 87 : 535-543, 1994.
PubMed
31) Kawaguchi H., Miyashita T., Herbst H., et al. : Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J. Clin. Invest., 92 : 1444-1450, 1993.
PubMed
32) Mori M., Kurozumi H., Akagi K., et al. : Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. N. Engl. J. Med., 327 : 58, 1992.
PubMed
33) Chen R.-L., Lin K.-H., Lin D.-T., et al. : Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br. J. Haematol., 89 : 282-290, 1995.
PubMed
34) Blanche S., Caniglia M., Fischer A., et al. : Epstein-Barr virus-associated hemophagocytic syndrome : clinical presentation and treatment. Pediatr. Hematol. Oncol., 6 : 233-235, 1989.
PubMed
35) Lipford E. H., Margolick J. B., Longo D. L., et al. : Angiocentric immunoproliferative lesions : a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood, 72 : 1674-1681, 1988.
PubMed
36) Harabuchi Y., Yamanaka N., Kataura A., et al. : Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335 : 128-130, 1990.
PubMed
37) Tsai T.-F., Su I.-J., Lu Y.-C., et al. : Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus. J. Am. Acad. Dermatol., 26 : 31-38, 1992.
PubMed
38) Medeiros L. J., Jaffe E. S., Chen Y.-Y., et al. : Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am. J. Surg. Pathol., 16 : 439-447, 1992.
PubMed
39) Tsang W.-Y.-W., Chan J.-K.-C., Yip T.-T.-C., et al. : In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum. Pathol., 25 : 758-765, 1994.
 
40) Kanavaros P., Lescs M., Criere J., et al. : Nasal T-cell lymphoma : a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood, 81 : 2688-2695, 1993.
 
41) Harabuchi Y., Imai S., Wakashima J., et al. : Nasal T-cell lymphoma causally associated with Epstein-Barr virus : clinicopathologic, phenotypic, and genotypic studies. Cancer, 77 : 2137-2149, 1996.
PubMed
42) inarovits J., Hu L-F., Imai S., et al. : Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J. Gen. Virol., 75 : 77-84, 1994.
PubMed
P.270 掲載の参考文献
1) 河敬世 : 慢性活動性EBウイルス感染症, 小児医学の進歩91A, 中山書店, 東京, 1991, pp. 185-195.
 
2) Rickinson A. B. : Chronic, symptomatic Epstein-Barr virus infections. Immunol. Today, 7 : 13-15, 1986.
PubMed
3) 河敬世 : 慢性活動性EBウイルス感染症の疾患概念と病態の多用性. 臨床とウイルス, 22 : 1-7, 1994.
 
4) 河敬世, 井上雅美, 坂田尚己 : リンパ系腫瘍とEBウイルス. CRC, 2 : 280-286, 1993.
 
5) 河敬世 : EBV感染症-最近の知見-. 臨床化学, 30 : 959-966, 1994.
 
6) Purtilo D.T., Cassel C.K., Yang J.S.P., et al. : X-linked recessive progressive combined variable immunodeficiency (Duncan disease). Lancet, 1 : 935-940, 1975.
 
7) 石原重彦, 河敬世, 岡田伸太郎, 他 : 本邦における慢性活動性EBウイルス感染症の特徴. 1. 臨床像および疫学的検討. 日児誌, 95 : 80-90, 1991.
 
8) 石原重彦, 多和昭雄, 岡田伸太郎, 他 : 本邦における慢性活動性EBウイルス感染症の特徴. 2. 検査成績と治療法からみた予後因子の検討. 日児誌, 96 : 1199-1207, 1992.
 
9) 石原重彦, 河敬世 : 慢性活動性EBウイルス感染症(シンポジウム). Int. J. Hematol., 59 : 88, 1994.
 
10) Kawa-Ha K., Franco E., Doi S., et al. : Successful treatment of chronic active Epstein-Barr virus infection with recombinant IL-2. Lancet, 1 : 154, 1987.
 
11) 堂本憲司, 矢田純一, 松本脩三 : 免疫不全症候群および難治性ウイルス感染症に対するインターロイキン-2(IL-2)の臨床応用. Biotherapy, 6 : 1149-1154, 1992.
 
12) Kawa-Ha K., Ishihara S., Ninomiya T., et al. : CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J. Clin. Invest., 84 : 51-55, 1989.
PubMed
13) 井上雅美, 倉橋浩樹, 石原重彦, 他 : 慢性活動性EBウイルス感染症にみられた脾内NK細胞増多症の2例. 医学のあゆみ, 162 : 493-440, 1992.
 
14) Papadopoulos E.B., Ladanyi M., Emanuel D., et al. : Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med., 330 : 1185-1191, 1994.
PubMed
15) Rooney C.M., Smith C.A., Ng C.Y.C., et al. : Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet, 345 : 9-13, 1995.
 
16) Pracher E., Panzer-Grumayer E.R, Zoubek A., et al. : Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplant., 13 : 655-658, 1994.
 
17) Gratama J.W., Lennette E.T., Lonngvist B., et al. : Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J. Med. Virol., 37 : 39-47, 1992.
 
P.277 掲載の参考文献
1) Yamanishi K., Okuno T., Shiraki K., et al. : Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet, 1 : 1065-1067, 1988.
PubMed
2) 植田浩司, 岡田賢司, 楠原浩一, 他 : 突発性発疹の臨床. 臨床とウイルス, 17 : 253-257, 1989.
Medical*Online
3) Tanaka K., Kondo T., Torigoe S., et al. : Human herpesvirus 7 : Another causal agent for roseola (exanthem subitum). J. Pediatr., 125 : 1-5, 1994.
PubMed
4) Wyatt LS., Rodriguez WJ., Balachandran N., et al. : Human herpesvirus 7 : Antigenic properties and prevalence in children and adults. J. Virol., 65 : 6260-6265, 1991.
PubMed
5) Clark D.A., Freeland J.M.L., Machie P.L.K., et al. : Prevalence of antibody to human herpesvirus 7 by age. J. Infect. Dis., 168 : 251-252, 1993.
 
6) Tanaka-Taya K., Kondo T., Mukai T., et al. : Seroepidemiological study of human herpesvirus-6 and-7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med. Virol, 48 : 88-94, 1996.
PubMed
7) Okuno T., Mukai T., Baba K., et al. : Outbreak of exanthem subitum in an orphanage. J. Pediatr., 119 : 759-761, 1991.
 
8) Leach C.T., Newton ER., McParlin S., et al. : Human herpesvirus 6 infection of the female genital tract. J. Infect. Dis., 169 : 1281-1283, 1994.
PubMed
9) Okuno T., Oishi H., Hayashi K., et al. : Human herpesvirus 6 and 7 in cervixes of pregnant women. J.Clin. Microbiol, 33 : 1968-1970, 1995.
PubMed
10) Mukai T., Yamamoto T., Kondo T., et al. : Molecular epidemiological studies of human herpesvirus 6 in families. J. Med. Virol., 42 : 224-227, 1994.
PubMed
11) Huang L.M., Lee C.Y., Chang M.H., et al. : Primary infections of Epstein-Barr virus, cytomegalovirus, and human herpesvirus-6. Arch. Dis. Child., 68 : 408-411, 1993.
PubMed
12) Black J.B., Inoue N, Kite-Powell K., et at. : Frequent isolation of human herpesvirus 7 from saliva. Virus Res., 29 : 91-98, 1993.
PubMed
13) Hidaka Y., Liu Y., Yamamoto M., et al. : Frequent isolation of human herpesvirus 7 from saliva samples. J. Med. Virol., 40 : 343-346, 1993.
 
14) Luca D.D., Mirandola T., Ravaioli T., et al. : Human herpesvirus 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J. Med. Virol., 45 : 462-468, 1995.
 
15) Suga S., Yoshikawa T., Asano Y., et al. : Human herpesvirus-6 infection (exanthem subitum) without rash. Pediatrics, 83 : 1003-1006, 1989.
PubMed
16) Asano Y., Suga S., Yoshikawa T., et al. : Human herpesvirus type 6 infection (exanthem subitum) without fever. J. Pediatr., 115 : 264-265, 1989.
PubMed
17) Balachandra K., Bowonkiratikachorn P., Poovijit B., et al. : Human herpesvirus 6 (HHV-6) infection and exanthem subitum in Thailand. Acta. Paediatr. Jpn., 33 : 434-439, 1991.
PubMed
18) Torigoe S., Kumamoto T., Koide W., et al. : Clinical manifestations associated with human herpesvirus 7 infection. Arch. Dis. Child., 72 : 518-519, 1995.
PubMed
19) Okuno T., Takahashi K., Balachandra K., et al. : Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J. Clin. Microbiol., 27 : 651-653, 1989.
PubMed
20) Kondo K., Hayakawa Y., Mori H., et al. : Detection by polymerase chain reaction amplification of human herpesvirus 6 DNA in peripheral blood of patients with exanthem subitum. J. Clin. Microbiol, 28 : 970-974, 1990.
PubMed
21) Pruksananonda P., Hall C.B., Insel R. A., et al. : Primary human herpesvirus 6 infection in young children. N. Engl. J Med., 326 : 1445-1450, 1992.
PubMed
22) Kondo K., Nagafuji H., Hata A., et al. : Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J. Infect. Dis., 167 : 1197-1200, 1993.
PubMed
23) Caserta M.T., Hall CB., Schnabel K., et al. : Neuroinvasion and persistence of human herpesvirus 6 in children. J. Infect. Dis., 170 : 1586-1589, 1994.
 
24) Ishiguro N, Yamada S., Takahashi T., et al. : Meningo-encephalitis associated with HHV-6 related exanthem subitum. Acta. Padiatr. Scand., 79 : 987-989, 1990.
 
25) Yoshikawa T., Nakashima T., Suga S., et al. : Human herpesvirus-6 DNA in cerebrospinal fluid of child with exanthem subitum and meningoencephalitis. Pediatrics, 89 : 888-890, 1992.
PubMed
26) Asano Y., Yoshikawa T., Kajita Y., et al. : Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch. Dis. Child., 67 : 1484-1485, 1992.
PubMed
27) Yanagihara K., Tanaka-Taya K., Itagaki Y., et al. : Human herpesvirus 6 mieningoencephalitis with sequelae. Pediatr. Infect. Dis. J., 14 : 240-242, 1995.
PubMed
28) Drobyski W.R, Knox K.K., Majewski D., et al. : Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N. Engl. J. Med., 330 : 1356-1360, 1994.
 
29) Tajiri H., et al. : Human herpesvirus-6 infection with liver injury in neonatal hepatitis. Lancet, 1 : 863, 1990.
 
30) 吉川哲史, 須賀定雄, 浅野喜造, 他 : Human herpesvirus-6の関与が考えられた劇症肝炎による乳児死亡例. 日児誌, 94 : 2209-2213, 1990.
 
31) Kitamura K., Ohta H., Ihara T., et al. : Idiopathic thrombocytopenic purpura after human herpesvirus 6 infection. Lancet, 344 : 830, 1994.
PubMed
32) Ablashi D.V., Lusso P., Hung C., et al. : Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (Human herpesvirus 6). Int. J. Cancer, 42 : 787-791, 1988.
PubMed
33) Burns W.H., Sandford G.R. : Susceptibility of human herpesvirus 6 to antivirals in vitro. J. Infect. Dis., 162 : 634-637, 1990.
PubMed
34) Oren I., Sobel J.D. : Human herpesvirus type 6 : Review. Clin. Infect. Dis., 14 : 741-746, 1992.
PubMed
P.284 掲載の参考文献
1) Drew W. L., Buhles W., Erlich K. S. : Management of herpes virus infections. In : The medical management of AIDS. 4th ed.(ed. by Sande M. A., Volberding P. A.), Saunders, Philadelphia, 1995, pp. 512-536.
 
2) Dix R. D., Waitzman D. M., Follansbee S., et al. : Herpes simplex virus type 2 encephalitis in two homosexual men with persistent adenopathy. Ann. Neurol., 17 : 230-206, 1985.
 
3) Englund J. A., Zimmerman M. E., Swierkosz E. M., et al. : Herpes simplex virus resistent toacyclovir : A study in a tertiary care center. Ann. Intern. Med., 112 : 416-422, 1990.
 
4) Erlich K. S., Mills J., Chatis P., et al. : Acyclovir-resistent herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med., 320 : 293-296, 1989.
PubMed
5) Safrin S., Crumpacker C., Chatis P., et al. : A controlled trial comparing foscarnet with vidarabine for acyclovir-resistent mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N. Engl. J. Med., 325 : 551-555, 1991.
 
6) Nusinoff-Lehrman S., Douglas J. M., Corey L., et al. : Recurrent genital herpes and suppressive oral acyclovir therapy : Relation between clinical outcome and in vitro sensitivity. Ann. Intern.Med., 104 : 786-790, 1986.
 
7) Friedman-Kien A. E., Lafleur F. L., Gendler E., et al. : Herpes zoster : A possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals. J. Am.Acad. Dermatol., 14 : 1023-1028, 1986.
PubMed
8) Ryder J. W., Croen K., Kleinschmidt-DeMasters B. K., et al. : Progressive encephalitis three months after resolution of cutaneous zoster in a patients with AIDS. Ann. Neurol., 19 : 182-188, 1986.
 
9) Safrin S., Berger T. G., Gilson I., et al. : Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann. Intern. Med., 115 : 19-21, 1991.
 
10) Jacobson M. A., Drew W. L., Feinberg J., et al. : Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J. Infect. Dis., 163 : 1348-1351, 1991.
PubMed
11) Chang Y., Cesarman E, Pessin M. S., et al. : Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266 : 1865-1869, 1994.
PubMed
12) Moore P. S., Chang Y. : Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med., 332 : 1181-1185, 1995.
PubMed
13) Boshoff C., Schulz T. F., Kennedy M. M., et al. : Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med., 1 : 1274-1278, 1995.
PubMed

書評

最近チェックした商品履歴

Loading...